<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Molecules</journal-id><journal-id journal-id-type="iso-abbrev">Molecules</journal-id><journal-id journal-id-type="publisher-id">molecules</journal-id><journal-title-group><journal-title>Molecules</journal-title></journal-title-group><issn pub-type="epub">1420-3049</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7587548</article-id><article-id pub-id-type="doi">10.3390/molecules25204737</article-id><article-id pub-id-type="publisher-id">molecules-25-04737</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Unravelling the Biological Activities of the <italic>Byttneria pilosa</italic> Leaves Using Experimental and Computational Approaches</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Jyoti</surname><given-names>Mifta Ahmed</given-names></name><xref ref-type="aff" rid="af1-molecules-25-04737">1</xref><xref ref-type="author-notes" rid="fn1-molecules-25-04737">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Barua</surname><given-names>Niloy</given-names></name><xref ref-type="aff" rid="af1-molecules-25-04737">1</xref><xref ref-type="author-notes" rid="fn1-molecules-25-04737">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Hossain</surname><given-names>Mohammad Shafaet</given-names></name><xref ref-type="aff" rid="af1-molecules-25-04737">1</xref><xref ref-type="aff" rid="af2-molecules-25-04737">2</xref><xref ref-type="author-notes" rid="fn1-molecules-25-04737">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Hoque</surname><given-names>Muminul</given-names></name><xref ref-type="aff" rid="af1-molecules-25-04737">1</xref></contrib><contrib contrib-type="author"><name><surname>Bristy</surname><given-names>Tahmina Akter</given-names></name><xref ref-type="aff" rid="af1-molecules-25-04737">1</xref></contrib><contrib contrib-type="author"><name><surname>Mahmud</surname><given-names>Shabnur</given-names></name><xref ref-type="aff" rid="af1-molecules-25-04737">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-2329-0867</contrib-id><name name-style="given-only"><given-names>Kamruzzaman</given-names></name><xref ref-type="aff" rid="af1-molecules-25-04737">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1330-2169</contrib-id><name><surname>Adnan</surname><given-names>Md.</given-names></name><xref ref-type="aff" rid="af1-molecules-25-04737">1</xref><xref ref-type="aff" rid="af3-molecules-25-04737">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6516-8662</contrib-id><name><surname>Chy</surname><given-names>Md. Nazim Uddin</given-names></name><xref ref-type="aff" rid="af1-molecules-25-04737">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2767-2646</contrib-id><name><surname>Paul</surname><given-names>Arkajyoti</given-names></name><xref ref-type="aff" rid="af4-molecules-25-04737">4</xref></contrib><contrib contrib-type="author"><name><surname>Hossain</surname><given-names>Mir Ezharul</given-names></name><xref ref-type="aff" rid="af1-molecules-25-04737">1</xref><xref rid="c1-molecules-25-04737" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3188-2272</contrib-id><name><surname>Emran</surname><given-names>Talha Bin</given-names></name><xref ref-type="aff" rid="af4-molecules-25-04737">4</xref><xref rid="c1-molecules-25-04737" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9215-9737</contrib-id><name><surname>Simal-Gandara</surname><given-names>Jesus</given-names></name><xref ref-type="aff" rid="af5-molecules-25-04737">5</xref><xref rid="c1-molecules-25-04737" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Andrade</surname><given-names>Paula B.</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-molecules-25-04737"><label>1</label>Department of Pharmacy, International Islamic University Chittagong, Chittagong 4318, Bangladesh; <email>mifta_ahmed@yahoo.com</email> (M.A.J.); <email>niloybaruaniloy@gmail.com</email> (N.B.); <email>bappyshafaet@gmail.com</email> (M.S.H.); <email>muminul359@gmail.com</email> (M.H.); <email>tahminabristy4@gmail.com</email> (T.A.B.); <email>mahmudshilpi56@gmail.com</email> (S.M.); <email>kamruzzamanarafat@gmail.com</email> (K.); <email>mdadnan1991.pharma@gmail.com</email> (M.A.); <email>nazim107282@gmail.com</email> (M.N.U.C.)</aff><aff id="af2-molecules-25-04737"><label>2</label>Department of Theoretical and Computational Chemistry, University of Dhaka, Dhaka 1000, Bangladesh</aff><aff id="af3-molecules-25-04737"><label>3</label>Department of Bio-Health Technology, Kangwon National University, Chuncheon 24341, Korea</aff><aff id="af4-molecules-25-04737"><label>4</label>Department of Pharmacy, BGC Trust University Bangladesh, Chittagong 4381, Bangladesh; <email>arka.bgctub@gmail.com</email></aff><aff id="af5-molecules-25-04737"><label>5</label>Nutrition and Bromatology Group, Department of Analytical and Food Chemistry, Faculty of Food Science and Technology, University of Vigo&#x02014;Ourense Campus, E32004 Ourense, Spain</aff><author-notes><corresp id="c1-molecules-25-04737"><label>*</label>Correspondence: <email>ezharul48@yahoo.com</email> (M.E.H.); <email>talhabmb@bgctub.ac.bd</email> (T.B.E.); <email>jsimal@uvigo.es</email> (J.S.-G.); Tel.: +88-01819-942214 (T.B.E.); +34-988-387000 (J.S.-G.)</corresp><fn id="fn1-molecules-25-04737"><label>&#x02020;</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>15</day><month>10</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>10</month><year>2020</year></pub-date><volume>25</volume><issue>20</issue><elocation-id>4737</elocation-id><history><date date-type="received"><day>28</day><month>8</month><year>2020</year></date><date date-type="accepted"><day>12</day><month>10</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 by the authors.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p><italic>Byttneria pilosa</italic> is locally known as Harijora, and used by the native hill-tract people of Bangladesh for the treatment of rheumatalgia, snake bite, syphilis, fractured bones, elephantiasis and an antidote for poisoning. The present study was carried out to determine the possible anti-inflammatory, analgesic, neuropharmacological and anti-diarrhoeal activity of the methanol extract of <italic>B. pilosa</italic> leaves (MEBPL) through in vitro, in vivo and in silico approaches. In the anti-inflammatory study, evaluated by membrane stabilizing and protein denaturation methods, MEBPL showed a significant and dose dependent inhibition. The analgesic effect of MEBPL tested by inducing acetic acid and formalin revealed significant inhibition of pain in both tests. During the anxiolytic evaluation, the extract exhibited a significant and dose-dependent reduction of anxiety-like behaviour in mice. Similarly, mice treated with MEBPL demonstrated dose-dependent reduction in locomotion effect in the open field test and increased sedative effect in the thiopental sodium induced sleeping test. MEBPL also showed good anti-diarrheal activity in both castor oil induced diarrheal and intestinal motility tests. Besides, a previously isolated compound (beta-sitosterol) exhibited good binding affinity in docking and drug-likeliness properties in ADME/T studies. Overall, <italic>B. pilosa</italic> is a biologically active plant and could be a potential source of drug leads, which warrants further advanced study.</p></abstract><kwd-group><kwd><italic>Byttneria pilosa</italic></kwd><kwd>anti-inflammatory</kwd><kwd>analgesic</kwd><kwd>anxiolytic</kwd><kwd>neuropharmacological</kwd><kwd>anti-diarrheal</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-molecules-25-04737"><title>1. Introduction</title><p>Arthritis is a fundamental autoimmune disease, causes chronic inflammation in the joints&#x02019; connective tissue, leads to progression of synovial inflammation and cartilage destruction [<xref rid="B1-molecules-25-04737" ref-type="bibr">1</xref>]. Many researchers reported that pro-inflammatory mediators like tumour necrosis factor (TNF)-alpha, interleukin (IL)-2 and enzymes are the potential stimulators of developing persistent and multiple disorders [<xref rid="B2-molecules-25-04737" ref-type="bibr">2</xref>]. Nevertheless, a direct or indirect relationship between arthritis and these mediators is not surprising. To lessen the rheumatoid arthritis, various non-steroidal anti-inflammatory drugs (NSAIDs) (e.g., aspirin, ibuprofen, indomethacin, etc.) are being used clinically, but have several limitations (i.e., insufficient therapeutic interventions) and undesired side effects, such as amnesia, memory disturbance, drowsiness and sexual dysfunction.</p><p>Similar to arthritis, pro-inflammatory mediators are also the common etiology of persistent pain. Different sorts of conventional therapy were implemented to relieve pain since primitive times. Recently, various kinds of pain killers have been introduced which are now emerging as intolerant for the management of pain [<xref rid="B3-molecules-25-04737" ref-type="bibr">3</xref>]. The manifestation of the addictive properties and unwanted side effects of presently used anti-nociceptive drugs have restricted their long-term application [<xref rid="B4-molecules-25-04737" ref-type="bibr">4</xref>]. In this regard, traditional medicinal from indigenous knowledge can be safe therapeutic agents. Therefore, exploration of novel bioactive compounds from medicinal plants can play a pivotal role in the discovery and development of a sustainable anti-nociceptive agent.</p><p>Pain and inflammation are another important dominant factor for mental and behavioural disarrays [<xref rid="B5-molecules-25-04737" ref-type="bibr">5</xref>]. Several neurotransmitters, including norepinephrine and serotonin have parallel expression pathways for both nociception and neuropsychiatric disorders [<xref rid="B6-molecules-25-04737" ref-type="bibr">6</xref>]. Thus, chronic pain and inflammation can contribute to developing anxiety-like complications [<xref rid="B7-molecules-25-04737" ref-type="bibr">7</xref>]. Some sedatives and hypnotic drugs are used to treat anxiety by persuading sleep inception. However, serious side effects like respiratory, digestive, immune system dysfunctions, physical dependence and tolerance are appearing due to regular use of currently obtainable sedative-hypnotic medications [<xref rid="B8-molecules-25-04737" ref-type="bibr">8</xref>]. Henceforth, it is extremely needed to develop a new sedative-hypnotic drug with less adverse effect to managing various psychiatric disorders.</p><p>Local inflammation in the intestine generally stimulates prostaglandin biosynthesis which produces an intestinal dysfunction by suppressing the ions and water reabsorption [<xref rid="B9-molecules-25-04737" ref-type="bibr">9</xref>,<xref rid="B10-molecules-25-04737" ref-type="bibr">10</xref>]. This deleterious effect leads to diarrhoea by manifesting in frequent bowel movement with wet stool and abdominal cramps. At present, diarrhoea is regarded as a life-threatening disease due to the substantial report of paediatric morbidity and mortality throughout the world. Diarrhoea severely strikes malnourished children in developing countries due to the lack of useful drug and upsurge in resistance to antibiotics [<xref rid="B11-molecules-25-04737" ref-type="bibr">11</xref>]. Consequently, safe and effective drugs from plant origins are being searched for that might be a vital source of alternative therapies.</p><p><italic>Byttneria pilosa</italic> Roxb. is locally known as Harijora, which belongs to the Sterculiaceae family. Due to its medicinal benefits, <italic>B. pilosa</italic> is very well-known among tribal communities (Chakma, Marma and Khumi) of Bangladesh [<xref rid="B12-molecules-25-04737" ref-type="bibr">12</xref>]. This plant was commonly found in Chittagong (specially hill tracts and forests area), Cox&#x02019;s Bazar and Sylhet, Bangladesh. The plant is a large woody climber being mortised, setaceous and having twigs. The leaves of the plant are suborbicular, palmately 3-lobed, and furry on both surfaces [<xref rid="B13-molecules-25-04737" ref-type="bibr">13</xref>]. The crushed stems of <italic>B. pilosa</italic> are applied for the treatment of boils, rheumatalgia, snake bite and syphilis. The Khumi community uses the tender stem paste for the treatment of fractured bones. In the Tripura community, a paste of root is applied in affected areas for the treatment of elephantiasis. In addition, juice from the root is used as an antidote in cases of poisoning. The plant also produces foam which is irritating to the eyes [<xref rid="B14-molecules-25-04737" ref-type="bibr">14</xref>]. A compound named beta-sitosterol was isolated from the roots of the <italic>B. pilosa</italic> by Fourier-transform infrared spectroscopy (FTIR) analysis and physicochemical properties.</p><p>However, despite such popularity and the medicinal value of this plant, to date there is still lack of scientific validation on the phytochemical and pharmacological points of view. Therefore, we have aimed to evaluate the presence of anti-inflammatory, analgesic, anxiolytic, locomotion, sedative and anti-diarrheal activity of the methanol extract of <italic>B. pilosa</italic> leaves. As one compound was identified for the plant by FTIR analysis, we carried out computational studies by using molecular docking, PASS prediction and ADME properties analysis.</p></sec><sec sec-type="results" id="sec2-molecules-25-04737"><title>2. Results and Discussion</title><p>Humans have been using natural-derived medicines since primitive times to prevent and treat different diseases [<xref rid="B15-molecules-25-04737" ref-type="bibr">15</xref>]. As a natural assortment, plant-derived medicines are the crucial wellspring of possibly helpful structures for the development of new compounds which could lead to establishing safe drugs [<xref rid="B16-molecules-25-04737" ref-type="bibr">16</xref>]. The physiological and therapeutic activities of a plant extract are disclosed through the phytochemical analysis. The presence of numerous phyto-constituents increases the possibility of having different kinds of therapeutic activities like anti-inflammatory, anti-nociceptive, antiviral, antimicrobial, anti-diarrheal, thrombolytic and so on. An important phytoconstituent &#x0201c;alkaloids&#x0201d; is very beneficial for the treatment of different disorders of both humans and animals [<xref rid="B17-molecules-25-04737" ref-type="bibr">17</xref>]. Phenolic compounds are reported to have anti-nociceptive, antioxidant, anti-inflammatory and anti-proliferative activities [<xref rid="B18-molecules-25-04737" ref-type="bibr">18</xref>,<xref rid="B19-molecules-25-04737" ref-type="bibr">19</xref>]; terpenoids are found to have antimicrobial, nematocidal, potent anti-hypertensive, anti-inflammatory, insecticidal and anti-parasitic properties [<xref rid="B20-molecules-25-04737" ref-type="bibr">20</xref>]; and flavonoids are responsible for analgesic, anti-diarrheal, antioxidant, anti-inflammatory, anti-allergic, antibacterial, antiviral and anticancer activities [<xref rid="B21-molecules-25-04737" ref-type="bibr">21</xref>]. In our study, the analysis of qualitative phytoconstituents of MEBPL revealed that various secondary metabolites are present like alkaloids, carbohydrates, glycosides, flavonoids, phenols, tannins, saponins, terpenoids, fixed oil, quinones and resins, but the absence of cholesterol and protein (<xref rid="molecules-25-04737-t001" ref-type="table">Table 1</xref>). These beneficial secondary metabolites provide diverse biological actions with state-of-the-art therapeutic interventions. However, by considering the phytochemical and ethnomedicinal value of this plant we scientifically explored the possible pharmacological potentials of <italic>B. pilosa</italic>.</p><sec id="sec2dot1-molecules-25-04737"><title>2.1. Effect of MEBPL on Anti-Inflammatory Activity</title><p>The possible anti-inflammatory effect of MEBPL was undertaken by membrane stabilization and protein denaturation assay. Lysosomal lysis and enzyme discharging are caused by the inflammation, thus, a different kind of disorder. The NSAIDs possess their remedial effect either by stabilizing lysosomal membranes or by preventing the release of enzymes from lysosomes [<xref rid="B22-molecules-25-04737" ref-type="bibr">22</xref>]. There are similarities between human red blood cell (HRBC) membranes and lysosomal membranes, as HRBC membranes may be lysed by the use of an injurious agent (e.g., phenyl-hydrazine), a hypotonic medium and heat. In our study, dose dependent haemolysis inhibition of MEBPL was found and the protection of haemolysis persuaded by the hypotonic solution significantly (<italic>p</italic> &#x0003c; 0.05) increased compared to the control. The percentages of inhibition of haemolysis were 4.67 &#x000b1; 1.24%, 15.41 &#x000b1; 3.04%, 33.44 &#x000b1; 1.61% and 44.88 &#x000b1; 2.27% for the extract, whereas the standard hydrocortisone exhibited inhibition of 60.56 &#x000b1; 2.67%, 70.66 &#x000b1; 1.83%, 78.17 &#x000b1; 1.47% and 85.45 &#x000b1; 0.84%, respectively, at the doses of 62.5, 125, 250 and 500 &#x003bc;g/mL (<xref ref-type="fig" rid="molecules-25-04737-f001">Figure 1</xref>). This outcome demonstrated a potential HRBC haemolysis inhibitory effect of MEBPL, indicating anti-inflammatory insight for the plant extract.</p><p>The chronic inflammatory response, such as arthritis, causes protein denaturation. The key mechanism of action of NSAIDs is to provide protection against denaturation of protein and play an important role in the treatment of inflammation [<xref rid="B23-molecules-25-04737" ref-type="bibr">23</xref>]. To determine such comparable action, we conducted tests of the protein denaturation inhibitory effect of different doses of MEBPL (<xref ref-type="fig" rid="molecules-25-04737-f002">Figure 2</xref>). The extract exhibited a significant (<italic>p</italic> &#x0003c; 0.05) and dose dependent anti-inflammatory effect. The highest percentage of inhibitory activity was found of 56.57 &#x000b1; 4.11% at the dose of 500 &#x003bc;g/mL for the extract; while at the same dose standard the drug diclofenac sodium produced 85.32 &#x000b1; 3.22% inhibition. The ability to inhibit hypotonic protein denaturation by MEBPL may provide a significant contribution to the anti-inflammatory properties. As a result, the extract exerts anti-inflammatory activity, as it gives significant protection against HRBC membrane lysis and provides reduction of protein denaturation. Several researches reported that presence of various phytoconstituents such as phenols, terpenoids and flavonoids [<xref rid="B24-molecules-25-04737" ref-type="bibr">24</xref>] which might be accountable for the anti-inflammatory activities of the plant.</p></sec><sec id="sec2dot2-molecules-25-04737"><title>2.2. Effect of MEBPL on Analgesic Activity</title><p>Nociception can cause oedema, leukocyte eruption and inflammation, which is activated or triggered by releasing pro-inflammatory mediators. The manifestation of abdominal constriction (writhing response) after inducing acetic acid (intraperitoneally) into the mice is a well-designed model for the study of visceral pain. This animal model also helps to evaluate the peripherally analgesic effect of the plant extract [<xref rid="B25-molecules-25-04737" ref-type="bibr">25</xref>]. In this test, pain sensation is perceived by producing pro-inflammatory endogenous mediators (prostaglandins, cytokines, histamine, lipoxygenase, cyclooxygenase and serotonin) in the peripheral tissue which not only influence the stimulation of prostaglandin but also enhance the capillary permeability progresses of inflammatory ache [<xref rid="B26-molecules-25-04737" ref-type="bibr">26</xref>]. Analgesics are the chemical substances that lower the amount of writhing by inhibiting prostaglandin synthesis [<xref rid="B27-molecules-25-04737" ref-type="bibr">27</xref>]. In the acetic acid writhing test, the MEBPL exposed a significant and dose dependent inhibition in the nociceptive nerve. The MEBPL respectively exhibited 24.73% and 33.87% inhibition of writhing response at 200 and 400 mg/kg doses, while the reference drug diclofenac sodium (10 mg/kg) showed 65.59% inhibition compared to the control (<xref rid="molecules-25-04737-t002" ref-type="table">Table 2</xref>).</p><p>Besides, the formalin induced licking test is a biphasic technique for both centrally and peripherally anti-nociceptive pain mediated by two different mechanisms. The early phase is related to the neurogenic pain and the late phase is due to the inflammatory pain. The NSAIDs inhibit the late phase whereas the narcotic drugs inhibit both phases [<xref rid="B28-molecules-25-04737" ref-type="bibr">28</xref>]. Here, MEBPL provided a dose dependent reduction of paw licking time in early phase at doses of 200 and 400 mg/kg (<xref rid="molecules-25-04737-t003" ref-type="table">Table 3</xref>). However, compared to the late phase of the control, a dose of 400 mg/kg significantly (<italic>p</italic> &#x0003c; 0.001) decreased latency to uneasiness. On the other hand, standard drugs decreased the time of paw licking significantly at both phases. Such significant inhibition in the analgesic activity exhibited by the plant might be due to the availability of several bioactive phytoconstituents such as alkaloids, phenols [<xref rid="B18-molecules-25-04737" ref-type="bibr">18</xref>], tannins [<xref rid="B29-molecules-25-04737" ref-type="bibr">29</xref>,<xref rid="B30-molecules-25-04737" ref-type="bibr">30</xref>] and flavonoids.</p></sec><sec id="sec2dot3-molecules-25-04737"><title>2.3. Effect of MEBPL on Anxiolytic Activity</title><p>The hole-board test model used to exhibit the anxiolytic activity of the extract. After administration of the extract, mice with increased of head dipping behaviour reflect as anxiolytic whereas hesitancy reflects anxiogenic state during the hole-board test. Generally anxiolytic drugs impose their activity by binding with the gamma aminobutyric acid (GABA) receptor in the brain, increasing GABAergic neurotransmission, as the GABA receptor is important for balancing the neural inhibition as well as excitation [<xref rid="B31-molecules-25-04737" ref-type="bibr">31</xref>]. In our experiment, the anxiolytic activity of MEBPL tested by hole-board test in mice is presented in <xref rid="molecules-25-04737-t004" ref-type="table">Table 4</xref>. The dose of 400 mg/kg of the extract exhibited significant (<italic>p</italic> &#x0003c; 0.01) increase in the number of head dipping (40.20 &#x000b1; 2.82) compared to the control, while the standard drug diazepam 1 mg/kg showed 58.20 &#x000b1; 4.02 number of head dipping. It is observed in our study that the head dipping behaviour of mice after the treatment of the extract increases as the dose is raised from 200 to 400 mg/kg, which revealed the anxiolytic potentiality of the extract.</p></sec><sec id="sec2dot4-molecules-25-04737"><title>2.4. Effect of MEBPL on Locomotor Activity</title><p>During the open field test, mice treated with MEBPL manifested central nervous system (CNS) depressive activity, such as decreases in exploration and locomotion. Diazepam is a drug of the benzodiazepine group and acts as a central sensory depressant through binding with the GABA receptor, moderates excitement and calms the recipient. Quantitatively, the most excitatory and inhibitory neurotransmitters are GABA and glutamate [<xref rid="B32-molecules-25-04737" ref-type="bibr">32</xref>]. Therefore, receptors regarding these two neurotransmitters always seem to be important targets for psychotropic drugs. Here MEBPL (200 and 400 mg/kg) significantly and dose dependently reduced the square movements in the open field test of locomotion activity (<xref ref-type="fig" rid="molecules-25-04737-f003">Figure 3</xref>). The number of squares travelled by the mice at dose 400 mg/kg was decreased significantly (<italic>p</italic> &#x0003c; 0.001) at all intervals over 120 min compared to the control group.</p></sec><sec id="sec2dot5-molecules-25-04737"><title>2.5. Effect of MEBPL on Sedative Activity</title><p>In the sedative activity test, the extract significantly (<italic>p</italic> &#x0003c; 0.01) and dose dependently showed reduction in the onset time of falling asleep and for longer duration compared to the control (<xref ref-type="fig" rid="molecules-25-04737-f004">Figure 4</xref>). The length of sleeping time at the doses of 200 and 400 mg/kg was 120.59 &#x000b1; 4.23 min and 132.31 &#x000b1; 5.05 min, respectively, whereas the reference standard drug exhibited 147.79 &#x000b1; 3.97 min sleeping. Diazepam (standard drug) produces anxiolytic as well as a sedative effect, as it minimizes the onset of rest and extended the duration of rest as well as reduced exploratory action [<xref rid="B33-molecules-25-04737" ref-type="bibr">33</xref>]. Similar response was observed after the treatment of MEBPL, which might be hyperpolarisation of the membrane and causes the CNS depressive effect, thus leading to sedative activity.</p></sec><sec id="sec2dot6-molecules-25-04737"><title>2.6. Effect of MEBPL on Anti-Diarrheal Activity</title><p>Castor oil, its most active metabolite (ricinoleic acid), is regarded as a well-known diarrheal agent. Irritation of the intestinal mucosa is attempted when ricinoleic acid is released from castor oil by the action of the lipase enzyme, this causes secretion of the prostaglandin and nitric oxide (inflammatory mediators) that lead to stimulation of the intestinal motility by suppressing electrolyte and water reabsorption [<xref rid="B34-molecules-25-04737" ref-type="bibr">34</xref>]. However, to unveil the anti-diarrheal effect of MEBPL, we conducted the castor-oil induced diarrheal test on mice. As shown in <xref rid="molecules-25-04737-t005" ref-type="table">Table 5</xref>, the extract expressively inhibited diarrhoea and defecation in a dose dependent way compared to the control group. In fact, a 400 mg/kg dose of the extract exposed more significant inhibition (<italic>p</italic> &#x0003c; 0.0001) in defecation and diarrhoea which was higher than the reference drug loperamide 5 mg/kg.</p><p>Besides, MEBPL showed significantly reduction in the peristalsis index. The dose of 400 mg/kg exhibited noteworthy reduction of peristalsis index by 51.30 &#x000b1; 5.04% (<italic>p</italic> &#x0003c; 0.001), while the standard loperamide (5 mg/kg) revealed 45.33 &#x000b1; 2.27% (<italic>p</italic> &#x0003c; 0.0001) reduction. Furthermore, a 400 mg/kg dose showed 49.13% inhibition of intestinal motility, whereas the reference loperamide (5 mg/kg) exhibited 54.51% inhibition compared to the control. The intestinal motility effect of MEBPL by inducing castor-oil summarized in <xref rid="molecules-25-04737-t006" ref-type="table">Table 6</xref>. However, the observed anti-diarrheal activity by the MEBPL could be the availability of secondary metabolites like flavonoids and tannins which can cause death of the worms in the gastrointestinal tract by selectively binding with free proteins [<xref rid="B35-molecules-25-04737" ref-type="bibr">35</xref>].</p></sec><sec id="sec2dot7-molecules-25-04737"><title>2.7. In Silico Studies</title><p>In this study, molecular docking was performed as it has been greatly used to predict the ligand-target interactions for gaining better insights into pharmacological activity of natural products [<xref rid="B36-molecules-25-04737" ref-type="bibr">36</xref>]. For determining better perceptions of the observed biological activity (anti-inflammatory, analgesic, anti-diarrheal, anxiolytic, locomotor and sedative) of <italic>B. pilosa</italic>, one compound (beta-sitosterol) was selected for the docking analysis where the result of docking study are shown in <xref rid="molecules-25-04737-t007" ref-type="table">Table 7</xref>. The present study showed that beta-sitosterol displayed &#x02212;5.01 kcal/mol docking score against the PDE4 (PDB ID: 4WCU) for anti-inflammatory activity. In the case of analgesic activity, beta-sitosterol did not posses any interaction against the COX1 receptor (PDB ID: 2OYE), whereas &#x02212;3.865 kcal/mol docking score was exhibited against the COX2 (PDB ID: 6COX) enzyme. The compound displayed &#x02212;2.041 Kcal/mol and &#x02212;4.273 kcal/mol docking score against the potassium channel (PDB ID: 4UUJ) and bromodomain of human BRD4 in complex with midazolam (PDB ID: 3U5K), respectively, for anxiolytic activity. In addition, it was found to possess the highest docking score of &#x02212;6.656 kcal/mol against serotonin transporter (PDB ID: 5I6X) for locomotor activity, while exhibiting &#x02212;4.494 kcal/mol docking score against bromodomain of human BRD4 (PDB ID: 3U5J). Furthermore, for anti-diarrhoeal docking analysis, beta-sitosterol showed &#x02212;2.01 kcal/mol against the <italic>Vibrio cholerae</italic> MARTX toxin (PDB ID: 3CJB). The results of binding interactions of the docking study are presented in <xref rid="molecules-25-04737-t008" ref-type="table">Table 8</xref> and <xref ref-type="fig" rid="molecules-25-04737-f005">Figure 5</xref>, <xref ref-type="fig" rid="molecules-25-04737-f006">Figure 6</xref> and <xref ref-type="fig" rid="molecules-25-04737-f007">Figure 7</xref>. Here, beta-sitosterol interacts with the 6COX through three hydrogen bonds and twelve hydrophobic interactions as shown in <xref rid="molecules-25-04737-t008" ref-type="table">Table 8</xref>; 5I6X through two hydrogen bonds and 11 hydrophobic interactions; 4WCU through 12 hydrophobic interactions; 4UUJ through one hydrogen bond and three hydrophobic interactions; 3U5K through nine hydrophobic interactions; 3U5J through 14 hydrophobic interactions and 3CJB through nine hydrophobic interactions. Of all the receptors, 6COX, 5I6X and 4UUJ showed the better binding affinity in both hydrogen bond and hydrophobic bonds interaction.</p><p>Moreover, to support our experimental studies, a computer based online tool &#x0201c;PASS&#x0201d; was used to predict different biological activity based on the structure of the compounds. In this study, the possible biological activities of beta-sitosterol were evaluated by the PASS online program (<xref rid="molecules-25-04737-t009" ref-type="table">Table 9</xref>). The results of this study were defined as Pa (probable activity) and Pi (probable inactivity), where the values of both Pa and Pi should be ranging from 0.000 to 1.000. The Pa value of beta-sitosterol for anti-nociceptive, anti-inflammatory, antisecretory, neurotransmitter uptake inhibitor, neurotrophic factor enhancer and neuropeptide Y4 antagonist activities were 0.558, 0.467, 0.427, 0.266, 0.218 and 0.288, respectively. This outcome is consistent with our experimental studies which exhibited that MEBPL has anti-nociceptive, anti-inflammatory and neuropharmacological activities, including other biological properties.</p><p>The bioactive compound (beta-sitosterol) was then further characterized by using ADME analysis to pursue the physiochemical, drug-likeness and pharmacokinetics characteristics. The absorption, distribution, metabolism and excretion (ADME) properties of beta-sitosterol for selective activity was assessed with the QikProp module of Schrodinger (<xref rid="molecules-25-04737-t010" ref-type="table">Table 10</xref>). The predicted properties of beta-sitosterol satisfied the Lipinski&#x02019;s rules of five [<xref rid="B37-molecules-25-04737" ref-type="bibr">37</xref>] where only one rule (Log P) of violation was observed.</p></sec></sec><sec id="sec3-molecules-25-04737"><title>3. Materials and Methods</title><sec id="sec3dot1-molecules-25-04737"><title>3.1. Plant Collection</title><p>On March 2019, fresh green leaves of <italic>B. pilosa</italic> were collected from Bhatiari, Chittagong, Bangladesh (GPS coordinates: 22&#x000b0;28&#x02032;4.7604&#x02032;&#x02032; N and 91&#x000b0;43&#x02032;38.7300&#x02032;&#x02032; E). The plant was identified by Sheikh Bokhtear Uddin, Department of Botany, University of Chittagong, Chittagong-4331, Bangladesh (accession number: 36186).</p></sec><sec id="sec3dot2-molecules-25-04737"><title>3.2. Preparation of Plant Extract</title><p>The green leaves were dried for 10 days below shade and floor. The ground leaves (310 mg) were soaked in adequate amount of methanol (95%). Importantly, methanol is known as the maximum common solvent that is used to extract most of the phyto-constituents found in natural materials. During the extraction, amber glass was used to keep methanol-soaked powder of the plant leaves and stored at 25 &#x000b0;C/room-temperature and permitted to draw for numerous days (5&#x02013;7) with continuous shaking and stirring. When the solvent become concentrated, the contents were decanted using cotton and then filtered via Whatman clear out paper No. 1. The solvent was evaporated with the help of a water tub to produce a viscous mass and then kept at room temperature.</p></sec><sec id="sec3dot3-molecules-25-04737"><title>3.3. Chemicals</title><p>All residual chemicals were of analytical grade. Hydrocortisone, bovine albumin serum, diclofenac sodium, diazepam and thiopental-Na were purchased from Square Pharmaceuticals Ltd. (Dhaka, Bangladesh), loperamide was collected from Beacon Pharmaceuticals (Dhaka, Bangladesh). The other chemicals like phosphate buffer, acetic acid and formalin were brought from local sources.</p></sec><sec id="sec3dot4-molecules-25-04737"><title>3.4. Experimental Animals</title><p>Animals (Swiss albino mice) of both sexes (25&#x02013;35 g) were procured from the Jahangirnagar University, Dhaka-1342, Bangladesh. The animals were housed according to standard guidelines (room temperature, 25 &#x000b1; 2 &#x000b0;C; relative humidity, 55&#x02013;60%, 12 h light/dark cycle) and provided sufficient meal and water supplies. For the in vivo tests, the mice were managed with the laboratory conditions for 14 days. The institutional animal ethical committee, Department of Pharmacy, International Islamic University Chittagong, Bangladesh approved the experimental study as stated by the governmental guidelines under the reference Pharm-P&#x00026;D-61/08&#x02032;16-130 [<xref rid="B38-molecules-25-04737" ref-type="bibr">38</xref>].</p></sec><sec id="sec3dot5-molecules-25-04737"><title>3.5. Acute Toxicity Study</title><p>Mice were separated into four groups of five mice in each. They were fasted overnight and then intraperitoneally administered MEBPL at the doses of 1000, 2000 and 3000 mg/kg, the only vehicle given to the mice of the control group. The animals were observed for three hours for any bizarre behaviour which included respiratory complexity, motor impairment and hyperexcitability. Moreover, the prevalence of mortality for individual groups was noted as much as 24 h after management [<xref rid="B39-molecules-25-04737" ref-type="bibr">39</xref>].</p></sec><sec id="sec3dot6-molecules-25-04737"><title>3.6. Phytochemical Screening</title><p>The phytoconstituents analysis of the methanol extract of <italic>B. pilosa</italic> leaves was done by following the previously described standard process. The secondary metabolites such as alkaloids, carbohydrates, glycoside, flavonoids, phenols, tannins, saponins, terpenoids, cholesterols, proteins, fixed oils, quinones and resins were determined [<xref rid="B40-molecules-25-04737" ref-type="bibr">40</xref>].</p></sec><sec id="sec3dot7-molecules-25-04737"><title>3.7. In Vitro Anti-Inflammatory Activity</title><sec id="sec3dot7dot1-molecules-25-04737"><title>3.7.1. Membrane Stabilization</title><p>Membrane stabilization activity of MEBPL was done by following a previously described method [<xref rid="B41-molecules-25-04737" ref-type="bibr">41</xref>]. The test solution contained 0.5 mL of dissimilar concentrations (62.5, 125, 250 and 500 &#x000b5;g/mL) of MEBPL with 1 mL of buffer (phosphate) solution, 2 mL of hyposaline and 0.5 mL of suspension of HRBC (human red blood cell). For the standard (diclofenac sodium), the same procedure was followed. The control solution contained all the chemicals except the extract and reference drug. Then the mixtures were placed in an incubator at 37 &#x000b0;C for 30 min, and followed by centrifugation at 3000 rpm for 20 min. The supernatant solutions were collected and the haemoglobin content in the supernatant solution was measured at 560 nm using UV-visible spectrophotometer. The membrane stabilization of MEBPL was calculated by using the following formula (Equation (1)):<disp-formula id="FD1-molecules-25-04737"><label>(1)</label><mml:math id="mm1"><mml:mrow><mml:mrow><mml:mi>M</mml:mi><mml:mi>e</mml:mi><mml:mi>m</mml:mi><mml:mi>b</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi><mml:mi>b</mml:mi><mml:mi>i</mml:mi><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>y</mml:mi><mml:mo>&#x02009;</mml:mo><mml:mo>=</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>A</mml:mi><mml:mn>1</mml:mn><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02212;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mi>A</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>/</mml:mo><mml:mi>A</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>&#x000a0;</mml:mo><mml:mo>&#x000d7;</mml:mo><mml:mo>&#x000a0;</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:mrow></mml:math></disp-formula>
where <italic>A</italic>1 = control absorbance, and <italic>A</italic>2 = sample absorbance.</p></sec><sec id="sec3dot7dot2-molecules-25-04737"><title>3.7.2. Inhibition of Protein Denaturation</title><p>Anti-inflammatory activity of the methanol extract of <italic>B. pilosa</italic> leaves was carried by the inhibition of albumin-protein denaturation [<xref rid="B42-molecules-25-04737" ref-type="bibr">42</xref>]. The test solution (0.5 mL) consisted of 0.45 mL of 0.5% <italic>w</italic>/<italic>v</italic> aqueous solution of bovine serum albumin and sample (0.05 mL) of dissimilar doses (62.5, 125, 250 and 500 &#x000b5;g/mL). Furthermore, 0.5 mL of control solution was also prepared (0.45 mL of 0.5% w/v bovine serum albumin + 0.05 mL of d.w.). Using 1 N HCl, pH was adjusted to 6.3 to all solutions including MEBPL and diclofenac sodium. All the test solutions were then kept at 37 &#x000b0;C in an incubator for 20 min and then the temperature was raised to 57 &#x000b0;C for 3 min. After cooling the sample, 2.5 mL of phosphate buffer was added to the above sample solutions. With the help of the ultraviolet (UV)-spectrophotometer, the absorbance was recorded at 416 nm. Inhibition percentage of albumin-protein denaturation was calculated as (Equation (2)):<disp-formula id="FD2-molecules-25-04737"><label>(2)</label><mml:math id="mm2"><mml:mrow><mml:mrow><mml:mi>P</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>h</mml:mi><mml:mi>i</mml:mi><mml:mi>b</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi>p</mml:mi><mml:mi>r</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>b</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>&#x000a0;</mml:mo><mml:mo>=</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>A</mml:mi><mml:mn>1</mml:mn><mml:mo>&#x000a0;</mml:mo><mml:mo>&#x02013;</mml:mo><mml:mo>&#x000a0;</mml:mo><mml:mi>A</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>/</mml:mo><mml:mi>A</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>&#x000a0;</mml:mo><mml:mo>&#x000d7;</mml:mo><mml:mo>&#x000a0;</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:mrow></mml:math></disp-formula>
where <italic>A</italic>1 = control absorbance, and <italic>A</italic>2 = sample absorbance.</p></sec></sec><sec id="sec3dot8-molecules-25-04737"><title>3.8. In Vivo Analgesic Activity</title><sec id="sec3dot8dot1-molecules-25-04737"><title>3.8.1. Writhing Inhibition Test by Inducing Acetic Acid</title><p>Analgesic effect of MEBPL was studied by the writhing inhibition of mice after inducing acetic acid [<xref rid="B43-molecules-25-04737" ref-type="bibr">43</xref>]. The experimental mice were separated into 4 different groups (<italic>n</italic> = 5) and were unfed for two hours before starting the test. Tween-80 (1%) solution at 10 mL/kg b.w. as negative control, diclofenac sodium (reference drug) at 10 mg/kg b.w. as positive control and doses of MEBPL at 200 and 400 mg/kg b.w., respectively, administered orally using gavage. After 30 min of administration, acetic acid (0.7%) was injected intraperitoneally into the treated animals and then the writhing response was noted for 20 min.</p></sec><sec id="sec3dot8dot2-molecules-25-04737"><title>3.8.2. Paw Licking Test by Inducing Formalin</title><p>Paw licking test by inducing formalin was carried out for the study of analgesic activity by using the previously described method [<xref rid="B44-molecules-25-04737" ref-type="bibr">44</xref>]. The management and treatment of each group (<italic>n</italic> = 5) of mice were described in the writhing inhibition test. After 30 min of the administration of sample dose, at the right hind paw of the mice, 20 &#x003bc;L formalin (2.5% <italic>v</italic>/<italic>v</italic>) was injected by using a micro syringe (26-guage needle) at the bottom of the dorsal surface of the skin. The early phase (first 5 min) paw licking and the late phase (15&#x02013;30 min) paw licking was recorded for the calculation.</p></sec></sec><sec id="sec3dot9-molecules-25-04737"><title>3.9. Anxiolytic Activity by Hole Board Experiment</title><p>Hole-board study was done to determine the anxiolytic activity of the plant extract [<xref rid="B45-molecules-25-04737" ref-type="bibr">45</xref>]. The apparatus consisted of 16 evenly distributed holes in a plane wooden space (40 &#x000d7; 40 cm<sup>2</sup>) in diameter. The mice were separated into four groups (<italic>n</italic> = 5). Group 1 treated with negative control (1% Tween-80), group 2 treated with positive control (diazepam 1 mg/kg), groups 3 and 4 received the plant extract dosages of 200 and 400 mg/kg, respectively. Thirty minutes after oral administration of vehicle or MEBPL and 15 min after administration of diazepam, respectively, every animal was positioned at the middle of the wooden space to freely move and the amount of dipping head into the holes was observed for each mouse and recorded for 5 min.</p></sec><sec id="sec3dot10-molecules-25-04737"><title>3.10. Locomotor Activity by Open Field Experiment</title><p>In the open field test of locomotor activity, the mice were separated into four groups containing five mice in each. The dosing of each group was carried out as described in anxiolytic section. After dosing, each mouse was placed into a four-sided box of 25 equivalent black and white coloured squares with dimensions of 60 &#x000d7; 60 &#x000d7; 60 cm<sup>3</sup>, for 3 min at 0, 30, 60, 90 and 120 min intervals and the movements were recorded [<xref rid="B46-molecules-25-04737" ref-type="bibr">46</xref>].</p></sec><sec id="sec3dot11-molecules-25-04737"><title>3.11. Sedative Activity by Thiopental-Sodium Induced Sleeping Time</title><p>The experimental mice were again separated into four groups (<italic>n</italic> = 5). The dosing was carried out as in the anxiolytic section. After 30 min of dosing, each mouse was treated with thiopental-Na (40 mg/kg b.w.) orally to induce sleep. The time from administration of thiopental-Na to loss of righting reflex (latent period) and also the time of the loss and retrieval of righting reflex (duration of sleep) were observed. The onset time of sleeping and the total duration of sleeping were noted for each mouse [<xref rid="B47-molecules-25-04737" ref-type="bibr">47</xref>].</p></sec><sec id="sec3dot12-molecules-25-04737"><title>3.12. Anti-Diarrheal Activity</title><sec id="sec3dot12dot1-molecules-25-04737"><title>3.12.1. Castor-Oil Induced Diarrhoea Test</title><p>To evaluate the anti-diarrheal effect of MEBPL, the method of castor-oil induced diarrhoea test was followed as described previously [<xref rid="B48-molecules-25-04737" ref-type="bibr">48</xref>]. The mice were separated into four groups (<italic>n</italic> = 5) and remained unfed for 24 h. Mice from groups 1, 2, 3 and 4, respectively, received 10 mL/kg of 1% Tween-80 orally as negative control, standard drug loperamide (5 mg/kg) as positive control, doses of 200 mg/kg b.w. of MEBPL and doses of 400 mg/kg b.w. of MEBPL. After 1 h, 1 mL castor oil was given orally to every mouse and they were placed separately into boxes of blotting white paper. For each mouse, the consistency and number of both wet and dry faecal drops were observed as well as noted after each hour interval over a 4-h period. The paper was changed after every hour. Afterward, the faeces (means) of the treated groups were compared to the control group and the percentage of inhibition of defecation was calculated using the following equation (Equation (3)):<disp-formula id="FD3-molecules-25-04737"><label>(3)</label><mml:math id="mm3"><mml:mrow><mml:mrow><mml:mo>%</mml:mo><mml:mo>&#x000a0;</mml:mo><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>h</mml:mi><mml:mi>i</mml:mi><mml:mi>b</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi>d</mml:mi><mml:mi>e</mml:mi><mml:mi>f</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mo>=</mml:mo><mml:mo>&#x000a0;</mml:mo><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>A</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mo>&#x02212;</mml:mo><mml:mo>&#x000a0;</mml:mo><mml:mi>B</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>/</mml:mo><mml:mi>A</mml:mi></mml:mrow><mml:mo>]</mml:mo></mml:mrow><mml:mo>&#x000a0;</mml:mo><mml:mo>&#x000d7;</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:mrow></mml:math></disp-formula>
where <italic>A</italic> = average of faeces number (control group), and <italic>B</italic> = average of faeces number (treated group).</p></sec><sec id="sec3dot12dot2-molecules-25-04737"><title>3.12.2. Gastro-Intestinal Motility Test</title><p>The previously described method by Mascolo et al. [<xref rid="B49-molecules-25-04737" ref-type="bibr">49</xref>] was used to carry gastro-intestinal motility experiment. The treatment was followed as described in the castor oil-induced diarrhoea test. Charcoal feed was prepared by mixing 10% charcoal with 5% gum-acacia and after 1 h of administration of the sample, 1 mL charcoal feed was given orally to each animal. After 1 h of application of charcoal, the mice were forgone and the length (cm) moved by the charcoal feed from the pylorus to caecum was recorded. The subsequent equations were used to calculate the percentage of inhibition and peristalsis index (Equations (4) and (5)):<disp-formula id="FD4-molecules-25-04737"><label>(4)</label><mml:math id="mm4"><mml:mrow><mml:mrow><mml:mo>%</mml:mo><mml:mo>&#x000a0;</mml:mo><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>h</mml:mi><mml:mi>i</mml:mi><mml:mi>b</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mo>=</mml:mo><mml:mo>&#x000a0;</mml:mo><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>X</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mo>&#x02212;</mml:mo><mml:mo>&#x000a0;</mml:mo><mml:mi>Y</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>/</mml:mo><mml:mi>X</mml:mi></mml:mrow><mml:mo>]</mml:mo></mml:mrow><mml:mo>&#x000a0;</mml:mo><mml:mo>&#x000d7;</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:mrow></mml:math></disp-formula>
<disp-formula id="FD5-molecules-25-04737"><label>(5)</label><mml:math id="mm5"><mml:mrow><mml:mrow><mml:mi>P</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mi>e</mml:mi><mml:mi>x</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mo>&#x000a0;</mml:mo><mml:mo>=</mml:mo><mml:mo>&#x000a0;</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>Y</mml:mi><mml:mo>/</mml:mo><mml:mi>X</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>&#x000a0;</mml:mo><mml:mo>&#x000d7;</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:mrow></mml:math></disp-formula>
where <italic>X</italic> = distance travelled by the charcoal for control (cm), and <italic>Y</italic> = distance travelled by the charcoal for treated group (cm).</p></sec></sec><sec id="sec3dot13-molecules-25-04737"><title>3.13. In Silico Studies</title><sec id="sec3dot13dot1-molecules-25-04737"><title>3.13.1. Selection of Compounds for In Silico Studies</title><p>Phytosterol is a steroidal compound having a similar structure to cholesterol, and more than 200 different types of sterols have been separated and isolated from different plants. Phytosterols are basically used as food supplements that having a cholesterol-lowering property. Phytosterols are available in the market in the form of capsules and tablets with other multivitamins. The average intake of naturally occurring phytosterols ranges between 150 and 450 mg/day. Beta-sitosterol is one of the naturally occurring phytosterols having steroidal moiety. Beta-sitosterol reduces cholesterol levels by competing with cholesterol for absorption in the intestine, and due to these aspects, it is valuable for cardiovascular protection. Beta-sitosterol also inhibits tumour growth, modulates the immune response, and has antioxidant capacity. In the future, beta-sitosterol could be a potential chemo-preventive agent for the treatment of various types of cancer, including prostatic carcinoma and breast cancer [<xref rid="B20-molecules-25-04737" ref-type="bibr">20</xref>].</p><p>In the present study, we have collected data regarding detailed pharmacological activities and analytical aspects of beta-sitosterol, which could be beneficial to the researchers, scientist including in the medical and pharmaceutical fields. Moreover, there are no previous reports on isolated compounds from <italic>B. pilosa</italic> to date except the isolation of beta-sitosterol. From this perspective, we have selected beta-sitosterol for computational studies such as molecular docking, PASS prediction, and ADME analysis.</p></sec><sec id="sec3dot13dot2-molecules-25-04737"><title>3.13.2. Molecular Docking Analysis</title><p>Beta-sitosterol was isolated from the roots of <italic>B. pilosa</italic> which was subjected molecular docking. The docking analysis was followed by the protocol of Sastry et al. (2013) [<xref rid="B50-molecules-25-04737" ref-type="bibr">50</xref>] and explained in detail in our previous studies [<xref rid="B11-molecules-25-04737" ref-type="bibr">11</xref>,<xref rid="B51-molecules-25-04737" ref-type="bibr">51</xref>]. Protein data bank was used to derive the 3D structures of the subsequent proteins: cyclooxygenase (COX)-1 (PDB ID: 2OYE) [<xref rid="B52-molecules-25-04737" ref-type="bibr">52</xref>], cyclooxygenase (COX)-2 (PDB ID: 6COX) [<xref rid="B53-molecules-25-04737" ref-type="bibr">53</xref>], serotonin transporter (PDB ID: 5I6X) [<xref rid="B54-molecules-25-04737" ref-type="bibr">54</xref>], potassium channel (PDB ID: 4UUJ) [<xref rid="B55-molecules-25-04737" ref-type="bibr">55</xref>], PDE4 complexed with inhibitor (PDB ID: 4WCU) [<xref rid="B56-molecules-25-04737" ref-type="bibr">56</xref>], bromodomain of human BRD4 (PDB ID: 3U5J) [<xref rid="B57-molecules-25-04737" ref-type="bibr">57</xref>], <italic>V. cholerae</italic> MARTX toxin and (PDB ID: 3CJB) [<xref rid="B58-molecules-25-04737" ref-type="bibr">58</xref>], and bromodomain of human BRD4 in complex with midazolam (PDB ID: 3U5K) [<xref rid="B57-molecules-25-04737" ref-type="bibr">57</xref>]. The molecular docking analysis was assessed by Schrodinger Maestro version 11.1 and the amino acid residues of the active sites of each receptor were given as follows: for 2OYE receptor, the amino acid residues were Val116, Arg120, Glu524, Leu531, Ala527, Gly526, Trp387, Met522, Leu384, Tyr385, Ser530, Val349, Leu352, Ile523, Ser353, Phe518, Tyr355, and Leu93; for 6COX receptor, the amino acid residues were Trp387, Tyr385, Gly526, Ala527, Leu384, Met522, Leu352, Phe518, Ala516, Gln192, Arg513, Ser353, Tyr355, Val116, Arg120, Leu531, Leu359, Val349, Val523, and Ser530; for 5I6X receptor, the amino acid residues were Val501, Phe335, Gly338, Ser336, Asp98, Ala96, Tyr95, Tyr176, Ser438, Ser439, Ile172, Ala169, Gly442, and Phe341; for 4UUJ receptor, the amino acid residues were Val93, Arg89, and Leu86; for 4WCU receptor, the amino acid residues were Phe432, Met273, Thr271, Asp318, Leu319, Tyr159, Trp332, Asn321, Thr333, Ile336, Phe340, Met337, Gln433, Gln369, Met357, Ile376, Phe372, and Leu436; for 3U5J receptor, the amino acid residues were Pro82, Trp81, Leu92, Met149, Ile146, Leu94, Asn140, and Phe83; for 3CJB receptor, the amino acid residues were Gly158, Leu16, Val159, Gly13, Gly15, Ser14, Gly302, Lys336, Tyr306, Met305, Glu214, Lys213, Thr303, Asp157, Gly301, Lys18, Gly156, and Asp154; and for 3U5K receptor, the amino acid residues were Asn140, Leu94, Leu92, Met149, Ile146, Trp81, Pro82, Val87, and Phe83.</p></sec><sec id="sec3dot13dot3-molecules-25-04737"><title>3.13.3. PASS Prediction Study</title><p>The beta-sitosterol (PubChem ID: 222284) was also used for PASS prediction analysis and the chemical structure for the compound was retrieved from the PubChem data base. PASS online server predicts the pharmacological activity of a compound as probable activity (Pa) and probable inactivity (Pi) and details were described in our previous study [<xref rid="B11-molecules-25-04737" ref-type="bibr">11</xref>].</p></sec><sec id="sec3dot13dot4-molecules-25-04737"><title>3.13.4. ADME Analysis</title><p>The pharmacokinetics parameters of the beta-sitosterol compound was analysed based on Lipinski&#x02019;s rule of five and assessed by QikProp (Schrodinger Maestro, version 11.1) [<xref rid="B59-molecules-25-04737" ref-type="bibr">59</xref>]. This application can measure the pharmacokinetic and physicochemical properties with molecular weight, hydrogen bond donor, hydrogen bond acceptor, high lipophilicity (Log P) and rotatable bonds of compounds.</p></sec></sec><sec id="sec3dot14-molecules-25-04737"><title>3.14. Statistical Analysis</title><p>The values were presented in mean &#x000b1; SEM (standard error mean), where <sup>a</sup>
<italic>p</italic> &#x0003c; 0.05, <sup>b</sup>
<italic>p</italic> &#x0003c; 0.01, <sup>c</sup>
<italic>p</italic> &#x0003c; 0.001 and <sup>d</sup>
<italic>p</italic> &#x0003c; 0.0001 were considered as statistically significant. The statistical analysis followed by one-way analysis of variance ANOVA (Dunnett&#x02019;s test) compared to the negative control (1% Tween-80) using GraphPad Prism version 6.0 (GraphPad Software Inc., San Diego, CA, USA).</p></sec></sec><sec sec-type="conclusions" id="sec4-molecules-25-04737"><title>4. Conclusions</title><p>Briefly, the experimental evidences support the medicinal value and potentiality of <italic>B. pilosa.</italic> Our study provides notable proof of significant and dose dependent anti-inflammatory activity of MEBPL. The experimental study also showed that MEBPL exhibited noticeable analgesic activity in different pain models. It has also been revealed that MEBPL possesses remarkable anxiolytic, locomotion and sedative effect. Furthermore, expressive anti-diarrheal activity increases the importance of this plant. In addition, molecular docking, PASS prediction and ADME analysis revealed that the selective compound beta-sitosterol could be a potential candidate for the named biological activity. Therefore, <italic>B. pilosa</italic> can be considered as a viable candidate for the development of new drugs as it has numerous pharmacological activities. However, to explore its biological activity and mechanisms on animals and humans necessitates further extensive studies.</p></sec></body><back><ack><title>Acknowledgments</title><p>Authors are very thankful to the Department of Pharmacy, International Islamic University Chittagong, Bangladesh for research facilities and other logistic support. The authors are also thankful to Shaikh Bokhtear Uddin for identifying the plant.</p></ack><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, M.A.J., N.B. and M.S.H.; methodology, M.A.J., N.B., M.S.H. and M.H.; software, M.A.J., N.B., M.S.H. and M.H.; validation, M.A.J., N.B. and M.S.H.; formal analysis, M.A.J., N.B. and M.S.H.; investigation, resources, data curation, and writing&#x02014;original draft preparation, M.A.J., N.B., M.S.H., M.H., T.A.B., S.M. and K.; writing&#x02014;review and editing, M.A., M.N.U.C., A.P. and T.B.E.; visualization, M.A.J., N.B., M.A., M.N.U.C, A.P. and M.S.H.; supervision, M.E.H., T.B.E. and J.S.-G.; project administration, M.E.H., T.B.E. and J.S.-G.; funding acquisition, M.E.H., T.B.E. and J.S.-G. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This research received no external funding.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><glossary><title>Abbreviations</title><p>MEBPL: Methanol extract of <italic>Byttneria pilosa</italic> leaves; HRBC: Human red blood cell; UV: Ultra-violet; b.w.: Body weight; d.w.: Distilled water; NSAIDs: Non-steroidal anti-inflammatory drugs; PASS: Prediction of Activity Spectra for Substances; ADME/T: Absorption, Distribution, Metabolism, Excretion, and Toxicity; SEM: Standard error mean.</p></glossary><ref-list><title>References</title><ref id="B1-molecules-25-04737"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cock</surname><given-names>I.E.</given-names></name><name><surname>Winnett</surname><given-names>V.</given-names></name><name><surname>Sirdaarta</surname><given-names>J.</given-names></name><name><surname>Matthews</surname><given-names>B.</given-names></name></person-group><article-title>The potential of selected Australian medicinal plants with anti-Proteus activity for the treatment and prevention of rheumatoid arthritis</article-title><source>Pharmacogn. Mag.</source><year>2015</year><volume>11</volume><fpage>190</fpage><pub-id pub-id-type="doi">10.4103/0973-1296.157734</pub-id><?supplied-pmid 26109767?><pub-id pub-id-type="pmid">26109767</pub-id></element-citation></ref><ref id="B2-molecules-25-04737"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amat</surname><given-names>N.</given-names></name><name><surname>Amat</surname><given-names>R.</given-names></name><name><surname>Abdureyim</surname><given-names>S.</given-names></name><name><surname>Hoxur</surname><given-names>P.</given-names></name><name><surname>Osman</surname><given-names>Z.</given-names></name><name><surname>Mamut</surname><given-names>D.</given-names></name><name><surname>Kijjoa</surname><given-names>A.</given-names></name></person-group><article-title>Aqueous extract of <italic>Dioscorea opposita</italic> thunb. normalizes the hypertension in 2K1C hypertensive rats</article-title><source>BMC Complement. Altern. Med.</source><year>2014</year><volume>14</volume><elocation-id>36</elocation-id><pub-id pub-id-type="doi">10.1186/1472-6882-14-36</pub-id><?supplied-pmid 24447776?><pub-id pub-id-type="pmid">24447776</pub-id></element-citation></ref><ref id="B3-molecules-25-04737"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cornelius</surname><given-names>M.</given-names></name><name><surname>Martel</surname><given-names>M.</given-names></name><name><surname>Jamison</surname><given-names>R.</given-names></name><name><surname>Weiss</surname><given-names>R.</given-names></name><name><surname>Edwards</surname><given-names>R.</given-names></name><name><surname>McHugh</surname><given-names>R.</given-names></name></person-group><article-title>(530) Distress intolerance and prescription opioid misuse among patients with chronic pain</article-title><source>J. Pain</source><year>2016</year><volume>17</volume><fpage>806</fpage><lpage>814</lpage><pub-id pub-id-type="doi">10.1016/j.jpain.2016.01.337</pub-id><pub-id pub-id-type="pmid">27058161</pub-id></element-citation></ref><ref id="B4-molecules-25-04737"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adnan</surname><given-names>M.</given-names></name><name><surname>Chy</surname><given-names>N.U.</given-names></name><name><surname>Kamal</surname><given-names>A.M.</given-names></name><name><surname>Barlow</surname><given-names>J.W.</given-names></name><name><surname>Faruque</surname><given-names>M.O.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Uddin</surname><given-names>S.B.</given-names></name></person-group><article-title>Evaluation of anti-nociceptive and anti-inflammatory activities of the methanol extract of <italic>Holigarna caustica</italic> (Dennst.) Oken leaves</article-title><source>J. Ethnopharmacol.</source><year>2019</year><volume>236</volume><fpage>401</fpage><lpage>411</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2019.01.025</pub-id><?supplied-pmid 30703495?><pub-id pub-id-type="pmid">30703495</pub-id></element-citation></ref><ref id="B5-molecules-25-04737"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adnan</surname><given-names>M.</given-names></name><name><surname>Chy</surname><given-names>N.U.</given-names></name><name><surname>Kamal</surname><given-names>A.M.</given-names></name><name><surname>Chowdhury</surname><given-names>R.</given-names></name><name><surname>Islam</surname><given-names>S.</given-names></name><name><surname>Hossain</surname><given-names>A.</given-names></name><name><surname>Tareq</surname><given-names>A.M.</given-names></name><name><surname>Bhuiyan</surname><given-names>I.H.</given-names></name><name><surname>Uddin</surname><given-names>N.</given-names></name><name><surname>Tahamina</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Unveiling pharmacological responses and potential targets insights of identified bioactive constituents of <italic>Cuscuta reflexa</italic> Roxb. leaves through in vivo and in silico approaches</article-title><source>Pharmaceuticals</source><year>2020</year><volume>13</volume><elocation-id>50</elocation-id><pub-id pub-id-type="doi">10.3390/ph13030050</pub-id></element-citation></ref><ref id="B6-molecules-25-04737"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>C.</given-names></name><name><surname>Pae</surname><given-names>C.-U.</given-names></name></person-group><article-title>Pain and depression: A neurobiological perspective of their relationship</article-title><source>Psychiatry Investig.</source><year>2015</year><volume>12</volume><fpage>1</fpage><pub-id pub-id-type="doi">10.4306/pi.2015.12.1.1</pub-id></element-citation></ref><ref id="B7-molecules-25-04737"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasanat</surname><given-names>A.</given-names></name><name><surname>Kabir</surname><given-names>M.S.H.</given-names></name><name><surname>Ansari</surname><given-names>A.</given-names></name><name><surname>Chowdhury</surname><given-names>T.A.</given-names></name><name><surname>Hossain</surname><given-names>M.M.</given-names></name><name><surname>Islam</surname><given-names>M.N.</given-names></name><name><surname>Ahmed</surname><given-names>S.</given-names></name><name><surname>Chy</surname><given-names>N.U.</given-names></name><name><surname>Adnan</surname></name><name><surname>Kamal</surname><given-names>A.M.</given-names></name></person-group><article-title>Ficus cunia Buch.-Ham. ex Roxb.(leaves): An experimental evaluation of the cytotoxicity, thrombolytic, analgesic and neuropharmacological activities of its methanol extract</article-title><source>J. Basic Clin. Physiol. Pharmacol.</source><year>2019</year><volume>30</volume><pub-id pub-id-type="doi">10.1515/jbcpp-2016-0140</pub-id></element-citation></ref><ref id="B8-molecules-25-04737"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pollmann</surname><given-names>A.S.</given-names></name><name><surname>Murphy</surname><given-names>A.L.</given-names></name><name><surname>Bergman</surname><given-names>J.C.</given-names></name><name><surname>Gardner</surname><given-names>D.M.</given-names></name></person-group><article-title>Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: A scoping review</article-title><source>BMC Pharmacol. Toxicol.</source><year>2015</year><volume>16</volume><elocation-id>19</elocation-id><pub-id pub-id-type="doi">10.1186/s40360-015-0019-8</pub-id><pub-id pub-id-type="pmid">26141716</pub-id></element-citation></ref><ref id="B9-molecules-25-04737"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gunaydin</surname><given-names>C.</given-names></name><name><surname>Bilge</surname><given-names>S.S.</given-names></name></person-group><article-title>Effects of Nonsteroidal Anti-Inflammatory Drugs at the Molecular Level</article-title><source>Eurasian J. Med.</source><year>2018</year><volume>50</volume><fpage>116</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.5152/eurasianjmed.2018.0010</pub-id><pub-id pub-id-type="pmid">30002579</pub-id></element-citation></ref><ref id="B10-molecules-25-04737"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pierce</surname><given-names>N.F.</given-names></name><name><surname>Carpenter</surname><given-names>C.C.</given-names></name><name><surname>Elliott</surname><given-names>H.L.</given-names></name><name><surname>Greenough</surname><given-names>W.B.</given-names></name></person-group><article-title>Effects of prostaglandins, theophylline, and cholera exotoxin upon transmucosal water and electrolyte movement in the canine jejunum</article-title><source>Gastroenterology</source><year>1971</year><volume>60</volume><fpage>22</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1016/S0016-5085(71)80003-3</pub-id><pub-id pub-id-type="pmid">5544090</pub-id></element-citation></ref><ref id="B11-molecules-25-04737"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adnan</surname><given-names>M.</given-names></name><name><surname>Chy</surname><given-names>N.U.</given-names></name><name><surname>Kamal</surname><given-names>A.M.</given-names></name><name><surname>Azad</surname><given-names>O.K.</given-names></name><name><surname>Paul</surname><given-names>A.</given-names></name><name><surname>Uddin</surname><given-names>S.B.</given-names></name><name><surname>Barlow</surname><given-names>J.W.</given-names></name><name><surname>Faruque</surname><given-names>M.O.</given-names></name><name><surname>Park</surname><given-names>C.H.</given-names></name><name><surname>Cho</surname><given-names>D.H.</given-names></name></person-group><article-title>Investigation of the biological activities and characterization of bioactive constituents of <italic>Ophiorrhiza rugosa</italic> var. prostrata (D. Don) &#x00026; Mondal leaves through in vivo, in vitro, and in silico approaches</article-title><source>Molecules</source><year>2019</year><volume>24</volume><fpage>1367</fpage></element-citation></ref><ref id="B12-molecules-25-04737"><label>12.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Khine</surname><given-names>K.K.</given-names></name></person-group><article-title>Phytochemical screening and some bioactivities of <italic>Byttneria pilosa</italic> Roxb. (Sat-le-pyat) Leaves and Stems</article-title><source>2nd Myanmar Korea Conference Research Journal</source><publisher-name>Dagon University</publisher-name><publisher-loc>Yangon, Myanmar</publisher-loc><year>2019</year><volume>Volume 2</volume><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.dagonuniversity.edu.mm/research/">https://www.dagonuniversity.edu.mm/research/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-07-30">(accessed on 30 July 2020)</date-in-citation></element-citation></ref><ref id="B13-molecules-25-04737"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibrahim</surname><given-names>M.Y.</given-names></name><name><surname>Ansari</surname><given-names>P.</given-names></name><name><surname>Riasat-ul-Islam</surname><given-names>A.K.M.</given-names></name><name><surname>Sultana</surname><given-names>M.</given-names></name><name><surname>Zhumur</surname><given-names>N.A.</given-names></name><name><surname>Mohammed</surname><given-names>S.</given-names></name></person-group><article-title>Evaluation of thrombolytic and cytotoxic activities of an ornamental medicinal plant: <italic>Byttneria pilosa</italic></article-title><source>Am. J. Biomed. Res.</source><year>2015</year><volume>3</volume><fpage>35</fpage><lpage>39</lpage></element-citation></ref><ref id="B14-molecules-25-04737"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaman</surname><given-names>R.</given-names></name><name><surname>Parvez</surname><given-names>M.</given-names></name><name><surname>Sekendar</surname><given-names>A.M.</given-names></name><name><surname>Islam</surname><given-names>M.</given-names></name></person-group><article-title>Possible anti-obesity activity of methanol extract of <italic>Byttneria pilosa</italic> Roxb. leaves</article-title><source>Middle-East. J. Sci. Res.</source><year>2015</year><volume>23</volume><fpage>1585</fpage><lpage>1589</lpage></element-citation></ref><ref id="B15-molecules-25-04737"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahman</surname><given-names>A.</given-names></name><name><surname>Sultana</surname><given-names>R.</given-names></name><name><surname>Bin Emran</surname><given-names>T.</given-names></name><name><surname>Islam</surname><given-names>M.S.</given-names></name><name><surname>Chakma</surname><given-names>J.S.</given-names></name><name><surname>Rashid</surname><given-names>H.</given-names></name><name><surname>Hasan</surname><given-names>C.M.M.</given-names></name><name><surname>Rahman</surname><given-names>M.A.</given-names></name></person-group><article-title>Effects of organic extracts of six Bangladeshi plants on in vitro thrombolysis and cytotoxicity</article-title><source>BMC Complement. Altern. Med.</source><year>2013</year><volume>13</volume><elocation-id>25</elocation-id><pub-id pub-id-type="doi">10.1186/1472-6882-13-25</pub-id><?supplied-pmid 23363538?><pub-id pub-id-type="pmid">23363538</pub-id></element-citation></ref><ref id="B16-molecules-25-04737"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rashid</surname><given-names>U.</given-names></name><name><surname>Khan</surname><given-names>M.R.</given-names></name><name><surname>Jan</surname><given-names>S.</given-names></name><name><surname>Bokhari</surname><given-names>J.</given-names></name><name><surname>Shah</surname><given-names>N.A.</given-names></name></person-group><article-title>Assessment of phytochemicals, antimicrobial and cytotoxic activities of extract and fractions from Fagonia olivieri (<italic>Zygophyllaceae</italic>)</article-title><source>BMC Complement. Altern. Med.</source><year>2013</year><volume>13</volume><elocation-id>167</elocation-id><pub-id pub-id-type="doi">10.1186/1472-6882-13-167</pub-id><?supplied-pmid 23842440?><pub-id pub-id-type="pmid">23842440</pub-id></element-citation></ref><ref id="B17-molecules-25-04737"><label>17.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Williamson</surname><given-names>E.M.</given-names></name></person-group><source>Herbal Neurotoxicity: An Introduction to Its Occurrence and Causes in Toxicology of Herbal Products</source><publisher-name>Springer</publisher-name><publisher-loc>Berlin/Heidelberg, Germany</publisher-loc><year>2017</year><fpage>345</fpage><lpage>362</lpage></element-citation></ref><ref id="B18-molecules-25-04737"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boussouf</surname><given-names>L.</given-names></name><name><surname>Boutennoune</surname><given-names>H.</given-names></name><name><surname>Kebieche</surname><given-names>M.</given-names></name><name><surname>Adjeroud-Abdellatif</surname><given-names>N.</given-names></name><name><surname>Al-Qaoud</surname><given-names>K.</given-names></name><name><surname>Madani</surname><given-names>K.</given-names></name></person-group><article-title>Anti-inflammatory, analgesic and antioxidant effects of phenolic compound from Algerian Mentha rotundifolia L. leaves on experimental animals</article-title><source>S. Afr. J. Bot.</source><year>2017</year><volume>113</volume><fpage>77</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/j.sajb.2017.07.003</pub-id></element-citation></ref><ref id="B19-molecules-25-04737"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>R.</given-names></name><name><surname>Chang</surname><given-names>X.</given-names></name><name><surname>Guo</surname><given-names>X.</given-names></name><name><surname>Brennan</surname><given-names>C.S.</given-names></name><name><surname>Li</surname><given-names>T.</given-names></name><name><surname>Fu</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>R.H.</given-names></name></person-group><article-title>Phenolic compounds, antioxidant activity, antiproliferative activity and bioaccessibility of Sea buckthorn (<italic>Hippopha&#x000eb; rhamnoides</italic> L.) berries as affected byin vitrodigestion</article-title><source>Food Funct.</source><year>2017</year><volume>8</volume><fpage>4229</fpage><lpage>4240</lpage><pub-id pub-id-type="doi">10.1039/C7FO00917H</pub-id><pub-id pub-id-type="pmid">29046908</pub-id></element-citation></ref><ref id="B20-molecules-25-04737"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guimar&#x000e3;es</surname><given-names>A.G.</given-names></name><name><surname>Serafini</surname><given-names>M.R.</given-names></name><name><surname>Quintans-J&#x000fa;nior</surname><given-names>L.J.</given-names></name></person-group><article-title>Terpenes and derivatives as a new perspective for pain treatment: A patent review</article-title><source>Expert Opin. Ther. Patents</source><year>2014</year><volume>24</volume><fpage>243</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1517/13543776.2014.870154</pub-id></element-citation></ref><ref id="B21-molecules-25-04737"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cushnie</surname><given-names>T.T.</given-names></name><name><surname>Lamb</surname><given-names>A.J.</given-names></name></person-group><article-title>Antimicrobial activity of flavonoids</article-title><source>Int. J. Antimicrob. Agents</source><year>2005</year><volume>26</volume><fpage>343</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2005.09.002</pub-id><pub-id pub-id-type="pmid">16323269</pub-id></element-citation></ref><ref id="B22-molecules-25-04737"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anosike</surname><given-names>C.A.</given-names></name><name><surname>Obidoa</surname><given-names>O.</given-names></name><name><surname>Ezeanyika</surname><given-names>L.U.</given-names></name></person-group><article-title>Membrane stabilization as a mechanism of the anti-inflammatory activity of methanol extract of garden egg (Solanum aethiopicum)</article-title><source>DARU J. Pharm. Sci.</source><year>2012</year><volume>20</volume><fpage>76</fpage><pub-id pub-id-type="doi">10.1186/2008-2231-20-76</pub-id></element-citation></ref><ref id="B23-molecules-25-04737"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizushima</surname><given-names>Y.</given-names></name></person-group><article-title>Inhibition of protein denaturation by antirheumatic or antiphlogistic agents</article-title><source>Arch. Int. Pharmacodyn.Ther.</source><year>1964</year><volume>149</volume><fpage>1</fpage><lpage>7</lpage><?supplied-pmid 14169882?><pub-id pub-id-type="pmid">14169882</pub-id></element-citation></ref><ref id="B24-molecules-25-04737"><label>24.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gillette</surname><given-names>J.R.</given-names></name><name><surname>Heinzelman</surname><given-names>R.V.</given-names></name><name><surname>Szmuszkovicz</surname><given-names>J.</given-names></name><name><surname>Leemann</surname><given-names>H.G.</given-names></name><name><surname>Stich</surname><given-names>K.</given-names></name><name><surname>Thomas</surname><given-names>M.</given-names></name><name><surname>Martin-Smith</surname><given-names>M.</given-names></name><name><surname>Khatoon</surname><given-names>T.</given-names></name><name><surname>Kunz</surname><given-names>W.</given-names></name></person-group><source>Progress in Drug Research/Fortschritte der Arzneimittelforschung/Progr&#x000e8;s des recherches pharmaceutiques</source><publisher-name>Springer Science and Business Media LLC</publisher-name><publisher-loc>Berlin/Heidelberg, Germany</publisher-loc><year>1963</year><fpage>279</fpage><lpage>346</lpage></element-citation></ref><ref id="B25-molecules-25-04737"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasan</surname><given-names>S.R.</given-names></name><name><surname>Akter</surname><given-names>R.</given-names></name><name><surname>Jamila</surname><given-names>M.</given-names></name><name><surname>Mazumder</surname><given-names>M.</given-names></name><name><surname>Alam</surname><given-names>M.</given-names></name><name><surname>Faruque</surname><given-names>A.</given-names></name><name><surname>Rana</surname><given-names>S.</given-names></name><name><surname>Hossain</surname><given-names>M.</given-names></name><name><surname>Rahman</surname><given-names>S.</given-names></name></person-group><article-title>Analgesic Activity of the Different Fractions of the Aerial Parts of Commelina benghalensis Linn</article-title><source>Int. J. Pharmacol.</source><year>2010</year><volume>6</volume><fpage>63</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.3923/ijp.2010.63.67</pub-id></element-citation></ref><ref id="B26-molecules-25-04737"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zakaria</surname><given-names>Z.A.</given-names></name><name><surname>Ghani</surname><given-names>Z.D.F.A.</given-names></name><name><surname>Nor</surname><given-names>R.N.S.R.M.</given-names></name><name><surname>Gopalan</surname><given-names>H.K.</given-names></name><name><surname>Sulaiman</surname><given-names>M.R.</given-names></name><name><surname>Jais</surname><given-names>A.M.M.</given-names></name><name><surname>Somchit</surname><given-names>M.N.</given-names></name><name><surname>Kader</surname><given-names>A.A.</given-names></name><name><surname>Ripin</surname><given-names>J.</given-names></name></person-group><article-title>Antinociceptive, anti-inflammatory, and antipyretic properties of an aqueous extract of <italic>Dicranopteris linearis</italic> leaves in experimental animal models</article-title><source>J. Nat. Med.</source><year>2008</year><volume>62</volume><fpage>179</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1007/s11418-007-0224-x</pub-id><?supplied-pmid 18404320?><pub-id pub-id-type="pmid">18404320</pub-id></element-citation></ref><ref id="B27-molecules-25-04737"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barua</surname><given-names>N.</given-names></name><name><surname>Aziz</surname><given-names>M.A.</given-names></name><name><surname>Tareq</surname><given-names>A.M.</given-names></name><name><surname>Sayeed</surname><given-names>M.A.</given-names></name><name><surname>Alam</surname><given-names>N.</given-names></name><name><surname>Alam</surname><given-names>N.U.</given-names></name><name><surname>Uddin</surname><given-names>M.A.</given-names></name><name><surname>Lyzu</surname><given-names>C.</given-names></name><name><surname>Emran</surname><given-names>T.B.</given-names></name></person-group><article-title>In vivo and in vitro evaluation of pharmacological activities of <italic>Adenia trilobata</italic> (Roxb.)</article-title><source>Biochem. Biophys. Rep.</source><year>2020</year><volume>23</volume><fpage>100772</fpage><pub-id pub-id-type="doi">10.1016/j.bbrep.2020.100772</pub-id><?supplied-pmid 32551370?><pub-id pub-id-type="pmid">32551370</pub-id></element-citation></ref><ref id="B28-molecules-25-04737"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khatun</surname><given-names>H.</given-names></name><name><surname>Majumder</surname><given-names>R.</given-names></name><name><surname>Mamun</surname><given-names>A.</given-names></name><name><surname>Alam</surname><given-names>E.K.</given-names></name><name><surname>Jami</surname><given-names>S.I.</given-names></name><name><surname>Alam</surname><given-names>B.</given-names></name></person-group><article-title>Preliminary pharmacological activity of the methanolic extract of <italic>Premna integrifolia</italic> barks in rats</article-title><source>Avicenna J. Phytomed.</source><year>2014</year><volume>4</volume><fpage>215</fpage><lpage>224</lpage><pub-id pub-id-type="pmid">25050319</pub-id></element-citation></ref><ref id="B29-molecules-25-04737"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Musa</surname><given-names>Y.M.</given-names></name><name><surname>Haruna</surname><given-names>A.K.</given-names></name><name><surname>Ilyas</surname><given-names>M.</given-names></name><name><surname>Yaro</surname><given-names>A.H.</given-names></name><name><surname>Ahmadu</surname><given-names>A.A.</given-names></name><name><surname>Usman</surname><given-names>H.</given-names></name></person-group><article-title>Phytochemical, Analgesic and Anti-Inflammatory Effects Of The Ethylacetate Extract Of The Leaves Of Pseudocedrella kotschyii</article-title><source>Afr. J. Tradit. Complement. Altern. Med.</source><year>2008</year><volume>5</volume><fpage>92</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.4314/ajtcam.v5i1.31261</pub-id><?supplied-pmid 20162060?><pub-id pub-id-type="pmid">20162060</pub-id></element-citation></ref><ref id="B30-molecules-25-04737"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramprasath</surname><given-names>V.R.</given-names></name><name><surname>Shanthi</surname><given-names>P.</given-names></name><name><surname>Sachdanandam</surname><given-names>P.</given-names></name></person-group><article-title>Immunomodulatory and Anti-inflammatory Effects of <italic>Semecarpus anacardium</italic> LINN. Nut Milk Extract in Experimental Inflammatory Conditions</article-title><source>Biol. Pharm. Bull.</source><year>2006</year><volume>29</volume><fpage>693</fpage><lpage>700</lpage><pub-id pub-id-type="doi">10.1248/bpb.29.693</pub-id><pub-id pub-id-type="pmid">16595901</pub-id></element-citation></ref><ref id="B31-molecules-25-04737"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olsen</surname><given-names>R.W.</given-names></name><name><surname>Tobin</surname><given-names>A.J.</given-names></name></person-group><article-title>Molecular biology of GABA A receptors</article-title><source>FASEB J.</source><year>1990</year><volume>4</volume><fpage>1469</fpage><lpage>1480</lpage><pub-id pub-id-type="doi">10.1096/fasebj.4.5.2155149</pub-id><pub-id pub-id-type="pmid">2155149</pub-id></element-citation></ref><ref id="B32-molecules-25-04737"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ezhou</surname><given-names>Y.</given-names></name><name><surname>Danbolt</surname><given-names>N.C.</given-names></name></person-group><article-title>GABA and Glutamate Transporters in Brain</article-title><source>Front. Endocrinol.</source><year>2013</year><volume>4</volume><fpage>165</fpage></element-citation></ref><ref id="B33-molecules-25-04737"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chowdhury</surname><given-names>M.R.</given-names></name><name><surname>Chowdhury</surname><given-names>K.H.</given-names></name><name><surname>Hanif</surname><given-names>N.B.</given-names></name><name><surname>Sayeed</surname><given-names>M.A.</given-names></name><name><surname>Mouah</surname><given-names>J.</given-names></name><name><surname>Mahmud</surname><given-names>I.</given-names></name><name><surname>Kamal</surname><given-names>A.T.M.M.</given-names></name><name><surname>Chy</surname><given-names>M.N.U.</given-names></name><name><surname>Adnan</surname><given-names>M.</given-names></name></person-group><article-title>An integrated exploration of pharmacological potencies of <italic>Bischofia javanica</italic> (Blume) leaves through experimental and computational modeling</article-title><source>Heliyon</source><year>2020</year><volume>6</volume><fpage>e04895</fpage><pub-id pub-id-type="doi">10.1016/j.heliyon.2020.e04895</pub-id><pub-id pub-id-type="pmid">32984603</pub-id></element-citation></ref><ref id="B34-molecules-25-04737"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ezenwali</surname><given-names>M.</given-names></name><name><surname>Njoku</surname><given-names>O.</given-names></name><name><surname>Okoli</surname><given-names>C.</given-names></name></person-group><article-title>Studies on the anti-diarrheal properties of seed extract of <italic>Monodora tenuifolia</italic></article-title><source>Int. J. App. Res. Nat. Prod.</source><year>2010</year><volume>2</volume><fpage>20</fpage><lpage>26</lpage></element-citation></ref><ref id="B35-molecules-25-04737"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raju</surname><given-names>G.S.</given-names></name><name><surname>Moghal</surname><given-names>M.R.</given-names></name><name><surname>Dewan</surname><given-names>S.M.R.</given-names></name><name><surname>Amin</surname><given-names>M.N.</given-names></name><name><surname>Billah</surname><given-names>M.</given-names></name></person-group><article-title>Characterization of phytoconstituents and evaluation of total phenolic content, anthelmintic, and antimicrobial activities of Solanum violaceum Ortega</article-title><source>Avicenna J. Phytomed.</source><year>2013</year><volume>3</volume><fpage>313</fpage><lpage>320</lpage><?supplied-pmid 25050288?><pub-id pub-id-type="pmid">25050288</pub-id></element-citation></ref><ref id="B36-molecules-25-04737"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>X.-Y.</given-names></name><name><surname>Zhang</surname><given-names>H.-X.</given-names></name><name><surname>Mezei</surname><given-names>M.</given-names></name><name><surname>Cui</surname><given-names>M.</given-names></name></person-group><article-title>Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery</article-title><source>Curr. Comput. Drug Des.</source><year>2011</year><volume>7</volume><fpage>146</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.2174/157340911795677602</pub-id><?supplied-pmid 21534921?><pub-id pub-id-type="pmid">21534921</pub-id></element-citation></ref><ref id="B37-molecules-25-04737"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipinski</surname><given-names>C.A.</given-names></name><name><surname>Lombardo</surname><given-names>F.</given-names></name><name><surname>Dominy</surname><given-names>B.W.</given-names></name><name><surname>Feeney</surname><given-names>P.J.</given-names></name></person-group><article-title>Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</article-title><source>Adv. Drug Deliv. Rev.</source><year>1997</year><volume>23</volume><fpage>3</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/S0169-409X(96)00423-1</pub-id></element-citation></ref><ref id="B38-molecules-25-04737"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmermann</surname><given-names>M.</given-names></name></person-group><article-title>Ethical guidelines for investigations of experimental pain in conscious animals</article-title><source>Pain</source><year>1983</year><volume>16</volume><fpage>109</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1016/0304-3959(83)90201-4</pub-id><pub-id pub-id-type="pmid">6877845</pub-id></element-citation></ref><ref id="B39-molecules-25-04737"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sulaiman</surname><given-names>M.R.</given-names></name><name><surname>Mohamad</surname><given-names>T.A.S.T.</given-names></name><name><surname>Mossadeq</surname><given-names>W.M.S.</given-names></name><name><surname>Moin</surname><given-names>S.</given-names></name><name><surname>Yusof</surname><given-names>M.</given-names></name><name><surname>Mokhtar</surname><given-names>A.F.</given-names></name><name><surname>Zakaria</surname><given-names>Z.A.</given-names></name><name><surname>Israf</surname><given-names>D.A.</given-names></name><name><surname>Lajis</surname><given-names>N.</given-names></name></person-group><article-title>Antinociceptive Activity of the Essential Oil of Zingiber zerumbet</article-title><source>Planta Medica</source><year>2010</year><volume>72</volume><fpage>107</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1055/s-0029-1185950</pub-id></element-citation></ref><ref id="B40-molecules-25-04737"><label>40.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Harborne</surname><given-names>A.</given-names></name></person-group><source>Phytochemical Methods: A Guide to Modern Techniques of Plant Analysis</source><publisher-name>Springer Science &#x00026; Business Media</publisher-name><publisher-loc>Berlin/Heidelberg, Germany</publisher-loc><year>1998</year></element-citation></ref><ref id="B41-molecules-25-04737"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Omale</surname><given-names>J.</given-names></name><name><surname>Okafor</surname><given-names>P.N.</given-names></name></person-group><article-title>Comparative antioxidant capacity, membrane stabilization, polyphenol composition and cytotoxicity of the leaf and stem of <italic>Cissus multistriata</italic></article-title><source>Afr. J. Biotechnol.</source><year>2008</year><volume>7</volume><fpage>3129</fpage><lpage>3133</lpage></element-citation></ref><ref id="B42-molecules-25-04737"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ansari</surname><given-names>P.</given-names></name><name><surname>Uddin</surname><given-names>J.</given-names></name><name><surname>Rahman</surname><given-names>M.</given-names></name><name><surname>Abdullah-Al-Mamun</surname><given-names>M.</given-names></name><name><surname>Islam</surname><given-names>R.</given-names></name><name><surname>Ali</surname><given-names>H.</given-names></name><name><surname>Reza</surname><given-names>A.A.</given-names></name></person-group><article-title>Anti-inflammatory, anti-diarrheal, thrombolytic and cytotoxic activities of an ornamental medicinal plant: <italic>Persicaria orientalis</italic></article-title><source>J. Basic Clin. Physiol. Pharmacol.</source><year>2017</year><volume>28</volume><fpage>51</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1515/jbcpp-2016-0023</pub-id><pub-id pub-id-type="pmid">27487493</pub-id></element-citation></ref><ref id="B43-molecules-25-04737"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arrigoni-Blank</surname><given-names>M.D.F.</given-names></name><name><surname>Dmitrieva</surname><given-names>E.G.</given-names></name><name><surname>Franzotti</surname><given-names>E.M.</given-names></name><name><surname>Antoniolli</surname><given-names>A.</given-names></name><name><surname>Andrade</surname><given-names>M.R.</given-names></name><name><surname>Marchioro</surname><given-names>M.</given-names></name></person-group><article-title>Anti-inflammatory and analgesic activity of <italic>Peperomia pellucida</italic> (L.) HBK (<italic>Piperaceae</italic>)</article-title><source>J. Ethnopharmacol.</source><year>2004</year><volume>91</volume><fpage>215</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2003.12.030</pub-id><pub-id pub-id-type="pmid">15120441</pub-id></element-citation></ref><ref id="B44-molecules-25-04737"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okokon</surname><given-names>J.E.</given-names></name><name><surname>Nwafor</surname><given-names>P.A.</given-names></name></person-group><article-title>Antiinflammatory, analgesic and antipyretic activities of ethanolic root extract of <italic>Croton zambesicus</italic></article-title><source>Pak. J. Pharm. Sci.</source><year>2010</year><volume>23</volume><fpage>385</fpage><lpage>392</lpage><pub-id pub-id-type="pmid">20884451</pub-id></element-citation></ref><ref id="B45-molecules-25-04737"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>&#x000d6;zt&#x000fc;rk</surname><given-names>Y.</given-names></name><name><surname>Aydin</surname><given-names>S.</given-names></name><name><surname>Beis</surname><given-names>R.</given-names></name><name><surname>Baser</surname><given-names>K.H.C.</given-names></name><name><surname>Berbero&#x0011f;lu</surname><given-names>H.</given-names></name></person-group><article-title>Effects of <italic>Hypericum perforatum</italic> L. and <italic>Hypericum calycinum</italic> L. extracts on the central nervous system in mice</article-title><source>Phytomedicine</source><year>1996</year><volume>3</volume><fpage>139</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1016/S0944-7113(96)80027-4</pub-id><pub-id pub-id-type="pmid">23194961</pub-id></element-citation></ref><ref id="B46-molecules-25-04737"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>B.D.</given-names></name><name><surname>Dandiya</surname><given-names>P.C.</given-names></name><name><surname>Gupta</surname><given-names>M.L.</given-names></name></person-group><article-title>A psychopharmacological analysis of behavior in rats</article-title><source>Jpn. J. Pharmacol.</source><year>1971</year><volume>21</volume><fpage>293</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1254/jjp.21.293</pub-id><pub-id pub-id-type="pmid">4397666</pub-id></element-citation></ref><ref id="B47-molecules-25-04737"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrini</surname><given-names>R.</given-names></name><name><surname>Miragoli</surname><given-names>G.</given-names></name><name><surname>Taccardi</surname><given-names>B.</given-names></name></person-group><article-title>Neuro-pharmacological studies on SB 5833, a new psychotherapeutic agent of the benzodiazepine class</article-title><source>Arzneimittelforschung</source><year>1974</year><volume>24</volume><fpage>2029</fpage><lpage>2032</lpage><?supplied-pmid 4156177?><pub-id pub-id-type="pmid">4156177</pub-id></element-citation></ref><ref id="B48-molecules-25-04737"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shoba</surname><given-names>F.</given-names></name><name><surname>Thomas</surname><given-names>M.</given-names></name></person-group><article-title>Study of antidiarrhoeal activity of four medicinal plants in castor-oil induced diarrhoea</article-title><source>J. Ethnopharmacol.</source><year>2001</year><volume>76</volume><fpage>73</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(00)00379-2</pub-id><pub-id pub-id-type="pmid">11378284</pub-id></element-citation></ref><ref id="B49-molecules-25-04737"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mascolo</surname><given-names>N.</given-names></name><name><surname>A Izzo</surname><given-names>A.</given-names></name><name><surname>Autore</surname><given-names>G.</given-names></name><name><surname>Barbato</surname><given-names>F.</given-names></name><name><surname>Capasso</surname><given-names>F.</given-names></name></person-group><article-title>Nitric oxide and castor oil-induced diarrhea</article-title><source>J. Pharmacol. Exp. Ther.</source><year>1994</year><volume>268</volume><fpage>291</fpage><lpage>295</lpage><?supplied-pmid 8301570?><pub-id pub-id-type="pmid">8301570</pub-id></element-citation></ref><ref id="B50-molecules-25-04737"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sastry</surname><given-names>G.M.</given-names></name><name><surname>Adzhigirey</surname><given-names>M.</given-names></name><name><surname>Day</surname><given-names>T.</given-names></name><name><surname>Annabhimoju</surname><given-names>R.</given-names></name><name><surname>Sherman</surname><given-names>W.</given-names></name></person-group><article-title>Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments</article-title><source>J. Comput. Mol. Des.</source><year>2013</year><volume>27</volume><fpage>221</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1007/s10822-013-9644-8</pub-id><?supplied-pmid 23579614?><pub-id pub-id-type="pmid">23579614</pub-id></element-citation></ref><ref id="B51-molecules-25-04737"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jahan</surname><given-names>I.</given-names></name><name><surname>Tona</surname><given-names>M.R.</given-names></name><name><surname>Sharmin</surname><given-names>S.</given-names></name><name><surname>Sayeed</surname><given-names>M.A.</given-names></name><name><surname>Tania</surname><given-names>F.Z.</given-names></name><name><surname>Paul</surname><given-names>A.</given-names></name><name><surname>Chy</surname><given-names>M.N.U.</given-names></name><name><surname>Rakib</surname><given-names>A.</given-names></name><name><surname>Emran</surname><given-names>T.B.</given-names></name><name><surname>Simal-Gandara</surname><given-names>J.</given-names></name></person-group><article-title>GC-MS Phytochemical Profiling, Pharmacological Properties, and In Silico Studies of <italic>Chukrasia velutina</italic> Leaves: A Novel Source for Bioactive Agents</article-title><source>Molecules</source><year>2020</year><volume>25</volume><elocation-id>3536</elocation-id><pub-id pub-id-type="doi">10.3390/molecules25153536</pub-id></element-citation></ref><ref id="B52-molecules-25-04737"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harman</surname><given-names>C.A.</given-names></name><name><surname>Turman</surname><given-names>M.V.</given-names></name><name><surname>Kozak</surname><given-names>K.R.</given-names></name><name><surname>Marnett</surname><given-names>L.J.</given-names></name><name><surname>Smith</surname><given-names>W.L.</given-names></name><name><surname>Garavito</surname><given-names>R.M.</given-names></name></person-group><article-title>Structural Basis of Enantioselective Inhibition of Cyclooxygenase-1 by S-&#x003b1;-Substituted Indomethacin Ethanolamides</article-title><source>J. Biol. Chem.</source><year>2007</year><volume>282</volume><fpage>28096</fpage><lpage>28105</lpage><pub-id pub-id-type="doi">10.1074/jbc.M701335200</pub-id><?supplied-pmid 17656360?><pub-id pub-id-type="pmid">17656360</pub-id></element-citation></ref><ref id="B53-molecules-25-04737"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurumbail</surname><given-names>R.G.</given-names></name><name><surname>Stevens</surname><given-names>A.M.</given-names></name><name><surname>Gierse</surname><given-names>J.K.</given-names></name><name><surname>McDonald</surname><given-names>J.J.</given-names></name><name><surname>Stegeman</surname><given-names>R.A.</given-names></name><name><surname>Pak</surname><given-names>J.Y.</given-names></name><name><surname>Gildehaus</surname><given-names>D.</given-names></name><name><surname>Iyashiro</surname><given-names>J.M.</given-names></name><name><surname>Penning</surname><given-names>T.D.</given-names></name><name><surname>Seibert</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents</article-title><source>Nat. Cell Biol.</source><year>1996</year><volume>384</volume><fpage>644</fpage><lpage>648</lpage><pub-id pub-id-type="doi">10.1038/384644a0</pub-id></element-citation></ref><ref id="B54-molecules-25-04737"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coleman</surname><given-names>J.A.</given-names></name><name><surname>Green</surname><given-names>E.M.</given-names></name><name><surname>Gouaux</surname><given-names>E.</given-names></name></person-group><article-title>X-ray structures and mechanism of the human serotonin transporter</article-title><source>Nat. Cell Biol.</source><year>2016</year><volume>532</volume><fpage>334</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1038/nature17629</pub-id></element-citation></ref><ref id="B55-molecules-25-04737"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lenaeus</surname><given-names>M.J.</given-names></name><name><surname>Burdette</surname><given-names>D.</given-names></name><name><surname>Wagner</surname><given-names>T.</given-names></name><name><surname>Focia</surname><given-names>P.J.</given-names></name><name><surname>Gross</surname><given-names>A.</given-names></name></person-group><article-title>Structures of kcsa in complex with symmetrical quaternary ammonium compounds reveal a hydrophobic binding site</article-title><source>Biochemistry</source><year>2014</year><volume>53</volume><fpage>5365</fpage><lpage>5373</lpage><pub-id pub-id-type="doi">10.1021/bi500525s</pub-id><?supplied-pmid 25093676?><pub-id pub-id-type="pmid">25093676</pub-id></element-citation></ref><ref id="B56-molecules-25-04737"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Felding</surname><given-names>J.</given-names></name><name><surname>S&#x000f8;rensen</surname><given-names>M.D.</given-names></name><name><surname>Poulsen</surname><given-names>T.D.</given-names></name><name><surname>Larsen</surname><given-names>J.</given-names></name><name><surname>Andersson</surname><given-names>C.</given-names></name><name><surname>Refer</surname><given-names>P.</given-names></name><name><surname>Engell</surname><given-names>K.</given-names></name><name><surname>Ladefoged</surname><given-names>L.G.</given-names></name><name><surname>Thormann</surname><given-names>T.</given-names></name><name><surname>Vinggaard</surname><given-names>A.M.</given-names></name><etal/></person-group><article-title>Discovery and Early Clinical Development of 2-{6-[2-(3,5-Dichloro-4-pyridyl)acetyl]-2,3-dimethoxyphenoxy}-N-propylacetamide (LEO 29102), a Soft-Drug Inhibitor of Phosphodiesterase 4 for Topical Treatment of Atopic Dermatitis</article-title><source>J. Med. Chem.</source><year>2014</year><volume>57</volume><fpage>5893</fpage><lpage>5903</lpage><pub-id pub-id-type="doi">10.1021/jm500378a</pub-id><?supplied-pmid 24984230?><pub-id pub-id-type="pmid">24984230</pub-id></element-citation></ref><ref id="B57-molecules-25-04737"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filippakopoulos</surname><given-names>P.</given-names></name><name><surname>Picaud</surname><given-names>S.</given-names></name><name><surname>Fedorov</surname><given-names>O.</given-names></name><name><surname>Keller</surname><given-names>M.</given-names></name><name><surname>Wrobel</surname><given-names>M.</given-names></name><name><surname>Morgenstern</surname><given-names>O.</given-names></name><name><surname>Bracher</surname><given-names>F.</given-names></name><name><surname>Knapp</surname><given-names>S.</given-names></name></person-group><article-title>Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family</article-title><source>Bioorg. Med. Chem.</source><year>2012</year><volume>20</volume><fpage>1878</fpage><lpage>1886</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2011.10.080</pub-id><pub-id pub-id-type="pmid">22137933</pub-id></element-citation></ref><ref id="B58-molecules-25-04737"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kudryashov</surname><given-names>D.S.</given-names></name><name><surname>Durer</surname><given-names>Z.A.O.</given-names></name><name><surname>Ytterberg</surname><given-names>A.J.</given-names></name><name><surname>Sawaya</surname><given-names>M.R.</given-names></name><name><surname>Pashkov</surname><given-names>I.</given-names></name><name><surname>Prochazkova</surname><given-names>K.</given-names></name><name><surname>Yeates</surname><given-names>T.O.</given-names></name><name><surname>Loo</surname><given-names>R.R.O.</given-names></name><name><surname>Loo</surname><given-names>J.A.</given-names></name><name><surname>Satchell</surname><given-names>K.J.F.</given-names></name><etal/></person-group><article-title>Connecting actin monomers by iso-peptide bond is a toxicity mechanism of the Vibrio cholerae MARTX toxin</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2008</year><volume>105</volume><fpage>18537</fpage><lpage>18542</lpage><pub-id pub-id-type="doi">10.1073/pnas.0808082105</pub-id><pub-id pub-id-type="pmid">19015515</pub-id></element-citation></ref><ref id="B59-molecules-25-04737"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Natarajan</surname><given-names>A.</given-names></name><name><surname>Sugumar</surname><given-names>S.</given-names></name><name><surname>Bitragunta</surname><given-names>S.</given-names></name><name><surname>Balasubramanyan</surname><given-names>N.</given-names></name></person-group><article-title>Molecular docking studies of (4Z, 12Z)-cyclopentadeca-4, 12-dienone from Grewia hirsuta with some targets related to type 2 diabetes</article-title><source>BMC Complement. Altern. Med.</source><year>2015</year><volume>15</volume><elocation-id>73</elocation-id><pub-id pub-id-type="doi">10.1186/s12906-015-0588-5</pub-id><?supplied-pmid 25885803?><pub-id pub-id-type="pmid">25885803</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="molecules-25-04737-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Percentages of inhibition of haemolysis of the erythrocyte membrane by methanol extract of <italic>B. pilosa</italic> leaves (MEBPL) and standard drug hydrocortisone. Results are mean &#x000b1; SEM (<italic>n</italic> = 3). <sup>a</sup>
<italic>p</italic> &#x0003c; 0.05, significantly different from control.</p></caption><graphic xlink:href="molecules-25-04737-g001"/></fig><fig id="molecules-25-04737-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Percentages of protein denaturation by methanol extract of <italic>B. pilosa</italic> leaves (MEBPL) and standard drug diclofenac sodium. Values are mean &#x000b1; SEM (<italic>n</italic> = 3). <sup>a</sup>
<italic>p</italic> &#x0003c; 0.05, significantly different from control.</p></caption><graphic xlink:href="molecules-25-04737-g002"/></fig><fig id="molecules-25-04737-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Locomotor effect of methanol extract of <italic>B. pilosa</italic> leaves (MEBPL) using open field test in mice. Values are stated as mean &#x000b1; SEM (<italic>n</italic> = 5). <sup>a</sup>
<italic>p</italic> &#x0003c; 0.05, <sup>b</sup>
<italic>p</italic> &#x0003c; 0.01, <sup>c</sup>
<italic>p</italic> &#x0003c; 0.001 and <sup>d</sup>
<italic>p</italic> &#x0003c; 0.0001 compared with control group followed by Dunnett&#x02019;s test of one-way ANOVA (GraphPad Prism 6.0).</p></caption><graphic xlink:href="molecules-25-04737-g003"/></fig><fig id="molecules-25-04737-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Sedative effect of methanol extract of <italic>B. pilosa</italic> leaves (MEBPL) by using thiopental sodium induced sleeping time test. Values are stated as mean &#x000b1; SEM (<italic>n</italic> = 5). <sup>b</sup>
<italic>p</italic> &#x0003c; 0.01 and <sup>d</sup>
<italic>p</italic> &#x0003c; 0.0001 compared with control group followed by Dunnett&#x02019;s test of one-way ANOVA (GraphPad Prism 6.0).</p></caption><graphic xlink:href="molecules-25-04737-g004"/></fig><fig id="molecules-25-04737-f005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>The best 2D representation found of the interactions between beta-sitosterol with (<bold>A</bold>) PDE4 enzyme (PDB ID: 4WCU), (<bold>B</bold>) COX-2 enzyme (PDB ID: 6COX), (<bold>C</bold>) potassium channel (PDB ID: 4UUJ), (<bold>D</bold>) bromodomain of human BRD4 in complex with midazolam (PDB ID: 3U5K), (<bold>E</bold>) serotonin transporter (PDB ID: 5I6X), and (<bold>F</bold>) bromodomain of human BRD4 in complex with alprazolam (PDB ID: 3U5J).</p></caption><graphic xlink:href="molecules-25-04737-g005"/></fig><fig id="molecules-25-04737-f006" orientation="portrait" position="float"><label>Figure 6</label><caption><p>Best representations of beta-sitosterol in the binding pocket of (<bold>A</bold>) PDE4 enzyme (PDB ID: 4WCU), (<bold>B</bold>) COX 2 enzyme (PDB ID: 6COX), (<bold>C</bold>) potassium channel (PDB ID: 4UUJ), (<bold>D</bold>) bromodomain of human BRD4 in complex with midazolam (PDB ID: 3U5K), (<bold>E</bold>) serotonin transporter (PDB ID: 5I6X), and (<bold>F</bold>) bromodomain of human BRD4 in complex with alprazolam (PDB ID: 3U5J).</p></caption><graphic xlink:href="molecules-25-04737-g006"/></fig><fig id="molecules-25-04737-f007" orientation="portrait" position="float"><label>Figure 7</label><caption><p>The best 2D (<bold>A</bold>) and 3D (<bold>B</bold>) representation of the interactions between beta-sitosterol with <italic>V. cholerae</italic> MARTX toxin (PDB ID: 3CJB).</p></caption><graphic xlink:href="molecules-25-04737-g007"/></fig><table-wrap id="molecules-25-04737-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-25-04737-t001_Table 1</object-id><label>Table 1</label><caption><p>Qualitative phytochemical screening of methanol extract of <italic>B. pilosa</italic> leaves.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Phytochemical Test </th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Results</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Alkaloids</td><td align="center" valign="middle" rowspan="1" colspan="1">++</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Carbohydrates</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Glycosides</td><td align="center" valign="middle" rowspan="1" colspan="1">++</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Flavonoids</td><td align="center" valign="middle" rowspan="1" colspan="1">++</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Phenols</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Tannins</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Saponins</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Terpenoids</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cholesterol</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Protein</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Fixed oil</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Quinones</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Resins</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">+</td></tr></tbody></table><table-wrap-foot><fn><p>Here, (++) = highly present, (+) = moderately present, and (-) = absent.</p></fn></table-wrap-foot></table-wrap><table-wrap id="molecules-25-04737-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-25-04737-t002_Table 2</object-id><label>Table 2</label><caption><p>Analgesic activity of methanol extract of <italic>B. pilosa</italic> leaves (MEBPL) in acetic acid induced writhing inhibition test in Swiss albino mice.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Treatment</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Writhing Number</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">(%) Inhibition</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Control</td><td align="center" valign="middle" rowspan="1" colspan="1">37.20 &#x000b1; 2.46</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Diclofenac-Na (10 mg/kg)</td><td align="center" valign="middle" rowspan="1" colspan="1">12.80 &#x000b1; 0.97 <sup>c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">65.59</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">MEBPL (200 mg/kg)</td><td align="center" valign="middle" rowspan="1" colspan="1">28.00 &#x000b1; 1.79 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">24.73</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MEBPL (400 mg/kg)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24.60 &#x000b1; 2.44 <sup>b</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33.87</td></tr></tbody></table><table-wrap-foot><fn><p>Values are given as mean &#x000b1; SEM (<italic>n</italic> = 5). <sup>a</sup>
<italic>p</italic> &#x0003c; 0.05, <sup>b</sup>
<italic>p</italic> &#x0003c; 0.01 and <sup>c</sup>
<italic>p</italic> &#x0003c; 0.001 compared with control group followed by Dunnett&#x02019;s test of one-way analysis of variance ANOVA (GraphPad Prism 6.0).</p></fn></table-wrap-foot></table-wrap><table-wrap id="molecules-25-04737-t003" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-25-04737-t003_Table 3</object-id><label>Table 3</label><caption><p>Effect of analgesic activity of methanol extract of <italic>B. pilosa</italic> leaves (MEBPL) by formalin induced paw induced test on Swiss albino mice.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Treatment</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Early Phase Paw Licking (s)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">% Inhibition of Early Phase</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Late Phase Paw Licking (s)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">% Inhibition of Late Phase</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Control</td><td align="center" valign="middle" rowspan="1" colspan="1">57.80 &#x000b1; 3.02</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">46.20 &#x000b1; 1.74</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Diclofenac-Na (10 mg/kg)</td><td align="center" valign="middle" rowspan="1" colspan="1">17.40 &#x000b1; 1.12 <sup>d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">69.89</td><td align="center" valign="middle" rowspan="1" colspan="1">16.00 &#x000b1; 1.14 <sup>d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">65.37</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">MEBPL (200 mg/kg)</td><td align="center" valign="middle" rowspan="1" colspan="1">40.40 &#x000b1; 2.25 <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">30.11</td><td align="center" valign="middle" rowspan="1" colspan="1">35.20 &#x000b1; 2.69 <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">23.81</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MEBPL (400 mg/kg)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">36.00 &#x000b1; 3.85 <sup>c</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">37.72</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">29.40 &#x000b1; 2.84 <sup>c</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">36.36</td></tr></tbody></table><table-wrap-foot><fn><p>Values are given as mean &#x000b1; SEM (<italic>n</italic> = 5). <sup>b</sup>
<italic>p</italic> &#x0003c; 0.01, <sup>c</sup>
<italic>p</italic> &#x0003c; 0.001 and <sup>d</sup>
<italic>p</italic> &#x0003c; 0.0001 compared with control group followed by Dunnett&#x02019;s test of one-way ANOVA (GraphPad Prism 6.0).</p></fn></table-wrap-foot></table-wrap><table-wrap id="molecules-25-04737-t004" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-25-04737-t004_Table 4</object-id><label>Table 4</label><caption><p>Anxiolytic effect of methanol extract of <italic>B. pilosa</italic> leaves (MEBPL) via hole-board test in mice.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Treatment</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Number of Head Dipping</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Control</td><td align="center" valign="middle" rowspan="1" colspan="1">24.80 &#x000b1; 3.07</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Diazepam 1 mg/kg</td><td align="center" valign="middle" rowspan="1" colspan="1">58.20 &#x000b1; 4.02 <sup>d</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">MEBPL 200 mg/kg</td><td align="center" valign="middle" rowspan="1" colspan="1">30.60 &#x000b1; 2.42</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MEBPL 400 mg/kg</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40.20 &#x000b1; 2.82 <sup>b</sup></td></tr></tbody></table><table-wrap-foot><fn><p>Values are stated as mean &#x000b1; SEM (<italic>n</italic> = 5). <sup>b</sup>
<italic>p</italic> &#x0003c; 0.01 and <sup>d</sup>
<italic>p</italic> &#x0003c; 0.0001 compared with control group followed by Dunnett&#x02019;s test of one-way ANOVA (GraphPad Prism 6.0). MEBPL = methanol extract of <italic>B. pilosa</italic> leaves.</p></fn></table-wrap-foot></table-wrap><table-wrap id="molecules-25-04737-t005" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-25-04737-t005_Table 5</object-id><label>Table 5</label><caption><p>The anti-diarrheal effect of methanol extract of <italic>B. pilosa</italic> leaves (MEBPL) on castor-oil induced Swiss albino mice.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Treatment</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Total Number of Faeces</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">% Inhibition of Defecation</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Total Number of Diarrheal Faeces</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">% Inhibition of Diarrhoea</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Control</td><td align="center" valign="middle" rowspan="1" colspan="1">14.70 &#x000b1; 0.41</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">7.05 &#x000b1; 0.25</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Loperamide (5 mg/kg)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.55 &#x000b1; 0.46 <sup>d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">62.24</td><td align="center" valign="middle" rowspan="1" colspan="1">2.05 &#x000b1; 0.15 <sup>c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">70.92</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">MEBPL (200 mg/kg)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.55 &#x000b1; 0.56 <sup>d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">55.44</td><td align="center" valign="middle" rowspan="1" colspan="1">2.30 &#x000b1; 0.22 <sup>c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">67.38</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MEBPL (400 mg/kg)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.50 &#x000b1; 0.34 <sup>d</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">62.59</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.80 &#x000b1; 0.33 <sup>d</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">74.46</td></tr></tbody></table><table-wrap-foot><fn><p>Values are given as mean &#x000b1; SEM (<italic>n</italic> = 5). <sup>c</sup>
<italic>p</italic> &#x0003c; 0.001 and <sup>d</sup>
<italic>p</italic> &#x0003c; 0.0001 compared with control group followed by Dunnett&#x02019;s test of one-way ANOVA (GraphPad Prism 6.0). MEBPL = methanol extract of <italic>B. pilosa</italic> leaves.</p></fn></table-wrap-foot></table-wrap><table-wrap id="molecules-25-04737-t006" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-25-04737-t006_Table 6</object-id><label>Table 6</label><caption><p>Intestinal motility effect of methanol extract of <italic>B. pilosa</italic> leaves by using charcoal as a marker.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Treatment</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Total Length of Intestine (cm)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Distance Travel by Charcoal (cm)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">% Peristalsis Index</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">% Inhibition</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Control</td><td align="center" valign="middle" rowspan="1" colspan="1">52.80 &#x000b1; 1.59</td><td align="center" valign="middle" rowspan="1" colspan="1">44.20 &#x000b1; 1.66</td><td align="center" valign="middle" rowspan="1" colspan="1">83.92 &#x000b1; 3.55</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Loperamide (5 mg/kg)</td><td align="center" valign="middle" rowspan="1" colspan="1">53.20 &#x000b1; 1.93</td><td align="center" valign="middle" rowspan="1" colspan="1">24.20 &#x000b1; 1.88 <sup>d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">45.33 &#x000b1; 2.27 <sup>d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">54.51</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">MEBPL (200 mg/kg)</td><td align="center" valign="middle" rowspan="1" colspan="1">55.60 &#x000b1; 3.31</td><td align="center" valign="middle" rowspan="1" colspan="1">31.80 &#x000b1; 1.66 <sup>c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">57.93 &#x000b1; 4.44 <sup>c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">42.80</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MEBPL (400 mg/kg)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">57.80 &#x000b1; 2.15</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">29.40 &#x000b1; 2.29 <sup>c</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">51.30 &#x000b1; 5.04 <sup>c</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49.13</td></tr></tbody></table><table-wrap-foot><fn><p>Values are given as mean &#x000b1; SEM (<italic>n</italic> = 5). <sup>c</sup>
<italic>p</italic> &#x0003c; 0.001 and <sup>d</sup>
<italic>p</italic> &#x0003c; 0.0001 compared with control group followed by Dunnett&#x02019;s test of one-way ANOVA (GraphPad Prism 6.0). MEBPL = methanol extract of <italic>B. pilosa</italic> leaves.</p></fn></table-wrap-foot></table-wrap><table-wrap id="molecules-25-04737-t007" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-25-04737-t007_Table 7</object-id><label>Table 7</label><caption><p>Molecular docking score of beta-sitosterol isolated from <italic>B. pilosa</italic> leaves.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compound</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">4WCU</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2OYE</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">6COX</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">4UUJ</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">3U5K</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">5I6X</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">3U5J</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">3CJB</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Beta-sitosterol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;5.01</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;3.865</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;2.041</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;4.273</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;6.656</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;4.494</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;2.01</td></tr></tbody></table><table-wrap-foot><fn><p>Here, 4WCU PDB ID for anti-inflammatory activity; 2OYE and 6COX PDB ID for analgesic activity; 4UUJ and 3U5K PDB ID for anxiolytic activity; 5I6X PDB ID for locomotor activity; 3U5J PDB ID for sedative activity; and 3CJB PDB ID for anti-diarrheal activity.</p></fn></table-wrap-foot></table-wrap><table-wrap id="molecules-25-04737-t008" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-25-04737-t008_Table 8</object-id><label>Table 8</label><caption><p>Binding interactions of the beta-sitosterol with the respective proteins for different biological activities.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Receptor PDB ID</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Hydrogen Bond Interactions</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Hydrophobic Bond Interactions</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">6COX</td><td align="center" valign="middle" rowspan="1" colspan="1">ASN 382 (2), THR 212</td><td align="center" valign="middle" rowspan="1" colspan="1">HIS 207 (Pi-Alkyl), HIS 214 (Pi-Alkyl), HIS 386 (Pi-Alkyl), HIS 388 (Pi-Alkyl), PHE 404 (Pi-Alkyl), VAL 291(2) (Alkyl), VAL 444 (Alkyl), VAL 447 (Alkyl), LEU 391 (Alkyl), LEU 408 (Alkyl), ALA 443 (Alkyl)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">5I6X</td><td align="center" valign="middle" rowspan="1" colspan="1">ARG 104</td><td align="center" valign="middle" rowspan="1" colspan="1">PHE 355(2) (Pi-Alkyl), PHE 341(2) (Pi-Alkyl), TYR 176(2) (Pi-Alkyl), ILE 172(3) (Alkyl), ALA 169 (Alkyl), ALA 173 (Alkyl)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">4WCU</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">ILE 336 (Alkyl), LEU 319 (Alkyl), MET 273(2) (Alkyl), PHE 340 (Pi-Alkyl), PHE 372 (Pi-Alkyl), PHE 432(2) (Pi-Alkyl), TYR 159(2) (Pi-Alkyl), HIS 164 (Pi-Alkyl), HIS 160 (Pi-Alkyl)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">4UUJ</td><td align="center" valign="middle" rowspan="1" colspan="1">THR 72</td><td align="center" valign="middle" rowspan="1" colspan="1">TYR 82 (3) (Pi-Alkyl)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">3U5K</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">TYR 139(2) (Pi-Alkyl), TYR 97 (Pi-Alkyl), PHE 83(2) (Pi-Alkyl), VAL 87 (Alkyl), LEU 94 (Alkyl), PRO 82 (Alkyl), CYS 136 (Alkyl)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">3U5J</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">VAL 87(2) (Alkyl), LEU 92 (Alkyl), LEU 94(2) (Alkyl), PRO 82(2) (Alkyl), ILE 146(3) (Alkyl), TRP 81 (Pi-Alkyl), TYR 139 (Pi-Alkyl), TYR 97(2) (Pi-Alkyl)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3CJB</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VAL 30(3) (Alkyl), PRO 32(3) (Alkyl), LEU 16(3) (Alkyl)</td></tr></tbody></table></table-wrap><table-wrap id="molecules-25-04737-t009" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-25-04737-t009_Table 9</object-id><label>Table 9</label><caption><p>PASS prediction of the beta-sitosterol isolated from <italic>B. pilosa</italic> leaves.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Properties</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Pa</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Pi</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Antinociceptive</td><td align="center" valign="middle" rowspan="1" colspan="1">0.558</td><td align="center" valign="middle" rowspan="1" colspan="1">0.014</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" rowspan="1" colspan="1">0.467</td><td align="center" valign="middle" rowspan="1" colspan="1">0.067</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Antisecretory</td><td align="center" valign="middle" rowspan="1" colspan="1">0.427</td><td align="center" valign="middle" rowspan="1" colspan="1">0.049</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Neurotransmitter uptake inhibitor</td><td align="center" valign="middle" rowspan="1" colspan="1">0.266</td><td align="center" valign="middle" rowspan="1" colspan="1">0.259</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Neurotrophic factor enhancer</td><td align="center" valign="middle" rowspan="1" colspan="1">0.218</td><td align="center" valign="middle" rowspan="1" colspan="1">0.051</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neuropeptide Y4 antagonist</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.288</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.200</td></tr></tbody></table><table-wrap-foot><fn><p>Here, (Pa) probable activity, and (Pi) probable inactivity.</p></fn></table-wrap-foot></table-wrap><table-wrap id="molecules-25-04737-t010" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-25-04737-t010_Table 10</object-id><label>Table 10</label><caption><p>ADME analysis of beta-sitosterol isolated from <italic>B. pilosa</italic> leaves.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">ADME Analysis of Beta-Sitosterol</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Molecular weight (acceptable range: 500)</td><td align="center" valign="middle" rowspan="1" colspan="1">414.7</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Hydrogen bond donor (acceptable range: &#x02264;5)</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Hydrogen bond acceptor (acceptable range: &#x02264;10)</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">High lipophilicity (expressed as Log P, &#x002c2;5)</td><td align="center" valign="middle" rowspan="1" colspan="1">9.3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rotatable bond</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6</td></tr></tbody></table></table-wrap></floats-group></article>